Energous (WATT) S-1/A 1 Dec 14 IPO registration (amended) Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2014
Document Information [Line Items]	'
Entity Registrant Name	'Energous Corp
Entity Central Index Key	'0001575793
Document Type	'S-1
Amendment Flag	'true
Amendment Description	'In connection with the Company’s update of information in the body of the Form S-1, the Company has provided conforming disclosures in the subsequent event footnotes of the interim financial statements for the three and nine months ended September 30, 2014.
Document Period End Date	30-Sep-14
Entity Filer Category	'Smaller Reporting Company

CONDENSED_BALANCE_SHEETS

CONDENSED BALANCE SHEETS (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Current assets:	'	'	'
Cash and cash equivalents	$18,420,480	$1,953,780	$994
Prepaid expenses and other current assets	279,674	127,197	0
Prepaid rent, current	80,000	0	'
Total current assets	18,780,154	2,080,977	994
Property and equipment, net	1,298,894	189,612	0
Prepaid rent, non-current	320,000	0	'
Deferred offering costs	0	88,319	0
Other assets	8,569	6,959	0
Total assets	20,407,617	2,365,867	994
Current liabilities:	'	'	'
Accounts payable	1,489,114	361,038	1,875
Accrued expenses	456,263	243,623	10,406
Convertible promissory notes, net	0	829,298	0
Derivative liabilities	0	6,277,000	0
Total current liabilities	1,945,377	7,710,959	12,281
Commitments and contingencies	'	'	'
Stockholders' equity (deficit)	'	'	'
Preferred Stock, $0.00001 par value, 10,000,000 and 0 shares authorized at September 30, 2014 and December 31, 2013, respectively; no shares issued or outstanding.	0	0	0
Common Stock, $0.00001 par value, 50,000,000 and 40,000,000 shares authorized at September 30, 2014 and December 31, 2013, respectively; 9,490,435 and 2,708,217 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively.	94	27	19
Additional paid-in capital	60,583,614	197,249	9,981
Accumulated deficit	-42,121,468	-5,542,368	-21,287
Total stockholders’ equity (deficit)	18,462,240	-5,345,092	-11,287
Total liabilities and stockholders’ equity (deficit)	$20,407,617	$2,365,867	$994

CONDENSED_BALANCE_SHEETS_Paren

CONDENSED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Preferred stock, par value (in dollars per share)	$0.00	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	0	5,000,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00	$0.00
Common stock, shares authorized	50,000,000	40,000,000	18,000,000
Common stock, shares issued	9,490,435	2,708,217	1,924,813
Common stock, shares outstanding	9,490,435	2,708,217	1,924,813

CONDENSED_STATEMENTS_OF_OPERAT

CONDENSED STATEMENTS OF OPERATIONS (USD $)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	14 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2013
Operating expenses:	'	'	'	'	'	'	'
Derivative instrument issuance	$0	$0	$9,040	$0	$887,062	$887,062	$887,062
Research and development	17,103	3,699,057	583,524	6,184,762	1,019,950	2,109,890	2,126,993
General and administrative	4,184	1,322,048	172,894	3,124,439	808,903	1,204,896	1,209,080
Marketing	0	809,333	32,014	2,036,793	32,014	233,622	233,622
Loss from operations	-21,287	-5,830,438	-797,472	-11,345,994	-2,747,929	-4,435,470	-4,456,757
Other (expense) income:	'	'	'	'	'	'	'
Change in fair value of derivative liabilities	0	0	-89,000	-26,265,177	-111,500	-177,000	-177,000
Interest, net	0	5,258	-286,891	-1,029,479	-383,380	-908,611	-908,611
Loss on retirement of fixed assets	'	-22,818	0	-22,818	0	'	'
Gain on debt extinguishment	'	0	0	2,084,368	0	'	'
Total	0	-17,560	-375,891	-25,233,106	-494,880	-1,085,611	-1,085,611
Net loss	($21,287)	($5,847,998)	($1,173,363)	($36,579,100)	($3,242,809)	($5,521,081)	($5,542,368)
Basic and diluted net loss per common share	($0.01)	($0.62)	($0.42)	($5.08)	($1.26)	($2.11)	'
Weighted average shares outstanding, basic and diluted	1,924,813	9,458,359	2,782,285	7,203,642	2,570,014	2,617,022	'

CONDENSED_STATEMENT_OF_CHANGES

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Oct. 29, 2012	$0	$0	$0	$0
Balance (in shares) at Oct. 29, 2012	'	0	'	'
Common stock sold to third party investor	10,000	19	9,981	0
Common stock sold to third party investor (in shares)	'	1,924,813	'	'
Net loss	-21,287	0	0	-21,287
Balance at Dec. 31, 2012	-11,287	19	9,981	-21,287
Balance (in shares) at Dec. 31, 2012	'	1,924,813	'	'
Common stock sold on January 28, 2013 to founder at $0.0052 per share	417	1	416	0
Common stock sold on January 28, 2013 to founder at $0.0052 per share (in shares)	'	80,201	'	'
Common stock sold on March 4, 2013 to affiliate of a director at $0.24 per share	160,000	7	159,993	0
Common stock sold on March 4, 2013 to affiliate of a director at $0.24 per share (in shares)	'	668,338	'	'
Common stock sold to third party investor	4,800	0	4,800	0
Common stock sold to third party investor (in shares)	'	20,051	'	'
Restricted common stock sold on May 14, 2013 under the 2013 Stock Plan of DvineWave, Inc., to consultant at $0.40 per share	35,464	1	35,463	0
Restricted common stock sold on May 14, 2013 under the 2013 Stock Plan of DvineWave, Inc., to consultant at $0.40 per share (in shares)	'	88,882	'	'
Repurchase and retirement of restricted common stock from consultant on November 30, 2013 at $0.40 per share	-29,553	-1	-29,552	0
Repurchase and retirement of restricted common stock from consultant on November 30, 2013 at $0.40 per share (in shares)	'	-74,068	'	'
Stock-based compensation	16,148	0	16,148	0
Net loss	-5,521,081	0	0	-5,521,081
Balance at Dec. 31, 2013	-5,345,092	27	197,249	-5,542,368
Balance (in shares) at Dec. 31, 2013	'	2,708,217	'	'
Stock-based compensation - amortization of stock options	1,070,939	0	1,070,939	0
Stock-based compensation - amortization of IR consultant warrant	198,983	0	198,983	0
Stock-based compensation - amortization of consultant restricted stock units (“RSUs”)	389,482	0	389,482	0
Issuance of shares to strategic investor, net of commission expense	900,000	2	899,998	0
Issuance of shares to strategic investor, net of commission expense (in shares)	'	210,527	'	'
Initial public offering on April 2, 2014, net of underwriter’s discount and offering costs of $2,816,149	24,783,851	46	24,783,805	0
Initial public offering on April 2, 2014, net of underwriter’s discount and offering costs of $2,816,149 (in shares)	'	4,600,000	'	'
Conversion of convertible notes on April 2, 2014	26,790,177	19	26,790,158	0
Conversion of convertible notes on April 2, 2014 (in shares)	'	1,930,128	'	'
Sale of IPO Underwriter Warrant on April 2, 2014	1,000	0	1,000	0
Sale of IPO Underwriter Warrant on April 2, 2014 (in shares)	'	0	'	'
Extinguishment of derivative for consulting warrant and financing warrant on June 25, 2014	5,752,000	0	5,752,000	0
Shares issued to landlord	500,000	0	500,000	0
Shares issued to landlord (in Shares)	'	41,563	'	'
Net loss	-36,579,100	0	0	-36,579,100
Balance at Sep. 30, 2014	$18,462,240	$94	$60,583,614	($42,121,468)
Balance (in shares) at Sep. 30, 2014	'	9,490,435	'	'

CONDENSED_STATEMENT_OF_CHANGES1

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) (USD $)	2 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Dec. 31, 2013
Common Stock Issued To Third Party Investor, Per Share Price	$0.01	'	$0.24
Common Stock Issued To Founder, Per Share Price	'	'	$0.01
Common Stock Issued To Affiliate Director, Per Share Price	'	'	$0.24
Restricted Common Stock Issued To Consultant, Per Share Price	'	'	$0.40
Repurchase And Retirement Of Restricted Common Stock From Consultant, Per Share Price	'	'	$0.40
Underwriters Discount and Offering Costs	'	$2,816,149	'

CONDENSED_STATEMENTS_OF_CASH_F

CONDENSED STATEMENTS OF CASH FLOWS (USD $)	2 Months Ended	9 Months Ended		12 Months Ended	14 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2013
Cash flows from operating activities:	'	'	'	'	'
Net loss	($21,287)	($36,579,100)	($3,242,809)	($5,521,081)	($5,542,368)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'	'	'
Depreciation and amortization	0	196,898	880	4,717	4,717
Stock based compensation	0	1,659,404	0	16,148	16,148
Amortization of debt discount	0	964,851	262,506	705,289	705,289
Warrant expense	0	0	724,000	724,000	724,000
Gain on conversion of notes payable and accrued interest	'	-2,084,368	0	'	'
Change in fair market value of derivative liabilities	0	26,265,177	111,500	177,000	177,000
Loss on retirement of fixed assets	'	22,818	0	'	'
Write off of abandoned trademark	0	'	'	4,725	4,725
Changes in operating assets and liabilities:	'	'	'	'	'
Prepaid expenses and other current assets	0	-152,477	-28,358	-127,197	-127,197
Other assets	0	-1,610	0	-6,959	-6,959
Accounts payable	1,875	1,128,076	173,557	359,163	361,038
Accrued expenses	10,406	89,361	156,755	233,217	243,623
Other current liabilities	'	0	16,000	'	'
Net cash used in operating activities	-9,006	-8,490,970	-1,825,969	-3,430,978	-3,439,984
Cash flows from investing activities:	'	'	'	'	'
Purchase of property and equipment	0	-815,500	-16,501	-194,329	-194,329
Costs of trademark	0	0	-4,725	-4,725	-4,725
Net cash used in investing activities	0	-815,500	-21,226	-199,054	-199,054
Cash flows from financing activities:	'	'	'	'	'
Proceeds from the sale of common stock	10,000	0	165,217	200,681	210,681
Proceeds from sale of restricted common stock	'	0	35,464	'	'
Proceeds from IPO, net of underwriter's discount and offering expenses	'	24,872,170	0	'	'
Proceeds from the sale of senior secured convertible notes	0	0	5,500,009	5,500,009	5,500,009
Proceeds from the sale of stock to strategic investor, net	'	900,000	0	'	'
Payment of deferred offering costs	0	'	'	-88,319	-88,319
Repurchase of restricted common stock	0	'	'	-29,553	-29,553
Sale of Warrant to IPO underwriter	'	1,000	0	'	'
Net cash provided by financing activities	10,000	25,773,170	5,700,690	5,582,818	5,592,818
Net increase in cash and cash equivalents	994	16,466,700	3,853,495	1,952,786	1,953,780
Cash and cash equivalents - beginning	0	1,953,780	994	994	0
Cash and cash equivalents - ending	994	18,420,480	3,854,489	1,953,780	1,953,780
Supplemental disclosure of non-cash financing activities:	'	'	'	'	'
Decrease in deferred offering costs charged to the IPO	'	88,319	0	'	'
Common stock issued upon conversion of notes payable and accrued interest payable	'	26,790,177	0	'	'
Increase in additional paid in capital upon extinguishment of derivative liability for warrants	'	5,752,000	0	'	'
Common stock issued to landlord for tenant improvements of $100,000 and prepaid rent of $400,000	'	500,000	0	'	'
Increase in accrued expenses for the purchase of property and equipment	'	$413,498	$0	'	'

CONDENSED_STATEMENTS_OF_CASH_F1

CONDENSED STATEMENTS OF CASH FLOWS (Parenthetical) (USD $)	9 Months Ended
	Sep. 30, 2014
Payments for Tenant Improvements	$100,000
Payments for Rent	$400,000

Business_Organization_Nature_o

Business Organization, Nature of Operations	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	'	'
	Note 1 — Business Organization, Nature of Operations	Note 1 — Business Organization, Nature of Operations
	Energous Corporation (f/k/a DvineWave Inc.) (the “Company”) was incorporated in Delaware on October 30, 2012 (inception). The Company is a technology company focused on developing technology that can enable wire-free charging of electronic devices at a distance and with complete mobility. The Company is developing solutions that enable wire-free transmission of energy from a transmitter to multiple receivers at distances of up to fifteen (15) feet. The Company is developing multiple generations of transmitter and receiver application specific integrated circuit chips (“ASICs”) whose designs will be licensed to customers, and that we believe will optimize our technology reducing size and cost, while increasing performance to a level that we believe will allow for them to be integrated into low-power devices, eliminating the need for a charging cord or pad to maintain charge. The Company submitted its first ASIC design to the wafer fabricator for production in November 2013. Since then, the Company submitted three additional ASICs to the wafer fabricator for production. Two of these ASICs will be used to demonstrate the Company’s WattUp technology in prototypical consumer products in conjunction with its strategic partners at the Consumer Electronics Show in January 2015. A fifth ASIC has also been designed and is currently under production at the wafer fabricator. Two of the five ASICs are expected to be incorporated into reference designs to be provided to the Company’s strategic partners to enable them to develop consumer-facing products for sale beginning late in the fourth quarter of 2015.	Energous Corporation (f/k/a DvineWave Inc.) (the “Company”) was incorporated in Delaware on October 30, 2012 (inception). The Company is a development stage technology company focused on developing a solution to delivering a wireless charging system, as a means of providing convenient, adaptive wireless power charging capabilities to low power fixed and mobile devices, such as mobile phones, tablets, toys, videogame controllers, watches, remote controls, smoke alarms, window covering deployment and retraction motors, installed sensors and night and emergency lighting fixtures that use or are capable of using a rechargeable battery. The Company is targeting both consumer and commercial enterprise markets that use such rechargeable fixed and mobile devices.
	On January 2, 2014, the board of directors and stockholders approved the name change for the Company to Energous Corporation from DvineWave Inc.	As of December 31, 2013, the Company had not yet completed the development of its product and has not yet recorded any revenues. Since inception, the Company’s primary activities have consisted of developing its business plan, raising capital, recruiting and hiring its executive team and developing its technology. To date, these activities have been funded through sales of common stock and the sale of Senior Secured Convertible Notes (“Convertible Notes”) (See Note 7, Private Placement).
	As of September 30, 2014, the Company had not yet completed the development of its product and had not yet recorded any revenues. Since inception, the Company’s primary activities have consisted of developing its technology, developing its business plan, raising capital, relocating to a larger facility and recruiting and hiring its workforce and executive team. To date, these activities have been funded primarily through the sale of Senior Secured Convertible Notes (“Convertible Notes”) (See Note 6 — Private Placement), the funding of the Company’s initial public offering (“IPO”), which was consummated on April 2, 2014 (See Note 8 — Stockholders’ Equity (Deficit)), the sale of the company common stock to a strategic investor (See Note 8 — Stockholders’ Equity (Deficit)) and the issuance of common stock to our landlord (See Note 7 — Commitments and Contingencies).	The Company is considered to be in the development stage, and as such, the Company’s financial statements are prepared in accordance with the Accounting Standards Codification (“ASC”) topic 915, “Development Stage Entities.” The Company is subject to all of the risks associated with development stage companies.
	Effective March 26, 2014, pursuant to authority granted by the stockholders and the Board of Directors of the Company, the Company implemented a 1-for-3.99 reverse split of the Company’s issued and outstanding common stock (the “Reverse Split”). All share and per share information in this Form 10-Q has been retroactively adjusted to reflect the Reverse Split.

Liquidity_and_Management_Plans

Liquidity and Management Plans	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Liquidity And Management Plan Disclosure [Abstract]	'	'
Liquidity And Management Plan Disclosure [Text Block]	'	'
	Note 2 — Liquidity and Management Plans	Note 2 — Going Concern and Management Plans
	The Company has not generated revenues since its inception and had net loss of $5,847,998 and $1,173,363 for the three months ended September 30, 2014 and 2013, respectively, and net losses of $36,579,100 and $3,242,809 for the nine months ended September 30, 2014 and 2013, respectively.	As of December 31, 2013, the Company’s cash on hand was $1,953,780. The Company has not generated revenues since its inception and has incurred net losses for the year ended December 31, 2013, for the period October 30, 2012 (inception) through December 31, 2012 and for the period October 30, 2012 (inception) through December 31, 2013 of $5,521,081, $21,287 and $5,542,368, respectively. During the year ended December 31, 2013, the Company has met its liquidity requirements principally through the private placement of convertible notes.
	As of September 30, 2014, the Company had cash on hand of $18,420,480. In April 2014, the Company completed its IPO of 4,600,000 shares of common stock through which the Company raised net proceeds of approximately $24.8 million. In connection with the completion of the IPO, the Company’s outstanding convertible notes and interest accrued thereon were converted into 1,833,336 and 96,792 shares, respectively, of common stock, thus extinguishing the debt associated with the notes. On April 4, 2014, the Company issued 210,527 shares of common stock to a strategic investor upon the receipt of net proceeds of $900,000 ($300,000 received on March 27, 2014, $700,000 received on April 4, 2014 less $100,000 to MDB Capital Group as a commission). On September 10, 2014, the Company issued 41,563 shares of common stock to the Company’s landlord as prepaid rent and tenant improvements. The company expects that cash on hand after the IPO will be sufficient to fund its operations into the fourth quarter of 2015.	As of December 31, 2013, the Company had a working capital deficiency and a stockholders’ deficit of $5,629,982 and $5,345,092, respectively.
	Research and development of new technologies is, by its nature, unpredictable. Although the Company will undertake development efforts with commercially reasonable diligence, there can be no assurance that our available resources including the net proceeds from the Company’s recently completed IPO and strategic investor financing will be sufficient to enable it to develop its technology to the extent needed to create future revenues to sustain its operations. The Company expects that it may choose to pursue additional financing, depending upon the market conditions, which could include follow-on equity offerings, debt financing, co-development agreements or other alternatives. Should the Company choose to pursue additional financing, there is no assurance that the Company would be able to do so on terms that it would find acceptable.	The Company expects that the cash it has available as of March 12, 2014 will fund its operations only until May, 2014. The Company intends to raise additional capital through its initial public offering (“IPO”), though there is no assurance that it will be able to do so. If the Company is unable to raise additional capital, the Company may have to curtail its research and development efforts, delay repayments of its Convertible Notes, delay payments to vendors, and/or initiate cost reductions, which would have a material adverse effect on the Company’s business, financial condition and results of operations. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statement do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Reverse_Split

Reverse Split	12 Months Ended
	Dec. 31, 2013
Class of Stock Disclosures [Abstract]	'
Reverse Split [Text Block]	'
	Note 3 — Reverse Split
	All share and per share amounts within these financial statements have been retroactively adjusted to reflect a 1-for-3.99 reverse split of the Company’s issued and outstanding common stock, as approved on March 26, 2014 by the Company’s stockholders and Board of Directors.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended											12 Months Ended
	Sep. 30, 2014											Dec. 31, 2013
Accounting Policies [Abstract]	'											'
Significant Accounting Policies [Text Block]	'											'
	Note 3 — Summary of Significant Accounting Policies											Note 4 — Summary of Significant Accounting Policies
	Basis of Presentation											Basis of Presentation
	The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. These condensed financial statements should be read in conjunction with the financial statements for the year ended December 31, 2013 and related notes thereto included elsewhere in the prospectus of which these financial statements are a part.											The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).
	Reclassification											Use of Estimates
	Certain amounts within the fiscal year 2013 consolidated financial statements have been reclassified in order to conform to the fiscal year 2014 presentation. These reclassification had no impact on previously reported results of operations or stockholder’s equity.											The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements as well as the reported expenses during the reporting periods.
	Use of Estimates											The Company’s significant estimates and assumptions include the valuation of the Company’s common stock and the valuation of derivative financial instruments, the amortization of deferred financing costs, the amortization and recoverability of capitalized patent costs and useful lives of long-lived assets, and income tax expense, some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates.
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the condensed financial statements as well as the reported expenses during the reporting periods.											Cash and Cash Equivalents
	The Company’s significant estimates and assumptions include the valuation of the Company’s common stock, the valuation of stock-based compensation instruments and the valuation of derivative financial instruments, the amortization of deferred financing costs and the useful lives of long-lived assets, and income tax expense. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates.											The Company maintains cash in bank accounts, consisting solely of deposits held at major banks, which, at times, may exceed federally insured limits. Cash equivalents include investments in open ended money market accounts held at the same major banks. The Company has not experienced any losses in such accounts and periodically evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.
	Research and Development											Property and Equipment
	Research and development expenses are charged to operations as incurred. For internally developed patents, all costs incurred to the point when a patent application is to be filed are expensed as incurred as research and development expense. Patent application costs, generally legal costs, are expensed as research and development costs until such time as the future economic benefits of such patents become more certain. The Company incurred research and development costs of $3,699,057 and $583,524 for the three months ended September 30, 2014 and 2013, respectively, and $6,184,762 and $1,019,950 for the nine months ended September 30, 2014 and 2013, respectively.											Property and equipment are stated at cost net of accumulated depreciation, which is recorded using the straight line method at rates sufficient to charge the cost of depreciable assets to operations over their estimated useful lives, which range from 3 to 7 years. Maintenance and repairs are charged to operations as incurred.
	Income Taxes											Deferred Offering Costs
	Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of September 30, 2014, no liability for unrecognized tax benefits was required to be reported. The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during the three and nine months ended September 30, 2014 and 2013.											Deferred offering costs consist principally of legal, accounting and other fees incurred through the balance sheet date that are directly related to the Company’s IPO and that will be charged to stockholders’ equity upon the receipt of the capital raised.
	Net Income (Loss) Per Common Share											Trademarks
	Basic net income (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method), the vesting of restricted stock units (“RSUs”), the exercise and/or conversion of the Company’s convertible notes (using the if-converted method). The computation of diluted loss per share excludes potentially dilutive securities of 3,060,301 and 3,210,126 for the three months ended September 30, 2014 and 2013, respectively, and 3,060,301 and 3,210,126 for the nine months ended September 30, 2014 and 2013, respectively, because their inclusion would be antidilutive.											Legal and filing fees incurred in connection with the registration of trademarks are capitalized.
	Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.											Research and Development
												Research and development expenses are charged to operations as incurred. For internally developed patents, all costs incurred to the point when a patent application is to be filed are expended as incurred as research and development expense. Patent application costs, generally legal costs, are expensed as research and development costs until such time as the future economic benefits of such patents become more certain. The Company incurred research and development costs of $2,109,890, $17,103 and $2,126,993 for the year ended December 31, 2013, for the period October 30, 2012 (inception) through December 31, 2012 and during the period from October 31, 2012 (inception) through December 31, 2013, respectively.
												Impairment of Long-lived Assets
			For the Three Months Ended					For the Nine Months Ended				The Company reviews for the impairment of long-lived assets, including trademarks, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Included in general and administrative expenses for the write off of an abandoned trademark is $4,725, $0 and $4,725 for the year ended December 31, 2013, for the period October 30, 2012 (inception) through December 31, 2012 and during the period from October 31, 2012 (inception) through December 31, 2013, respectively.
			September 30,					September 30,				Income Taxes
			2014			2013		2014		2013		The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse.
	Convertible Notes – principal			—			2,650,858		—		2,650,858	For the year ended December 31, 2013 and for the period October 30, 2012 (inception) through December 31, 2012, the Company had approximately $2,108,000 and $17,000, respectively, of research and development expenses capitalized for federal income tax purposes, with amortization commencing upon the Company receiving an economic benefit from the related research. For the period October 30, 2012 (inception) through December 31, 2012, $4,000 of organization costs were capitalized and will be amortized for federal income tax purposes over 15 years. Accordingly, as of December 31, 2013, the Company had approximately $2,263,391 gross federal and state net operating loss carryovers (“NOLs”). For the year ended December 31, 2013 and for the period October 30, 2012 (inception) through December 31, 2012, the deferred tax assets in connection with the net operating loss carryover, the research and development costs and the organizational costs were fully reserved, and the Company’s effective tax rate was 0%.
	Convertible Notes – accrued interest			—			60,135		—		60,135	In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the future generation of taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. Based on this assessment, management has established a full valuation allowance against all of the net deferred tax assets for each period, since it is more likely than not that all of the deferred tax assets will not be realized.
	Consulting Warrant to purchase common stock			278,228			278,228		278,228		278,228	Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of December 31, 2013, no liability for unrecognized tax benefits was required to be reported. The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded for the year ended December 31, 2013 or for the period October 30, 2012 (inception) through December 31, 2012.
	Financing Warrant to purchase common stock			152,778			220,905		152,778		220,905	Net Loss Per Common Share
	IPO Warrants to purchase common stock			460,000			—		460,000		—	Basic net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share are computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of the conversion of the Company’s convertible notes and warrants (using the if-converted method). The computation of basic loss per share for the year ended December 31, 2013 and for the period October 30, 2012 (inception) through December 31, 2012 excludes potentially dilutive securities of 3,525,907 and 0, respectively, because their inclusion would be antidilutive. As a result, the computations of net loss per share for each period presented is the same for both basic and fully diluted.
	IR Consulting Warrant			36,000			—		36,000		—	Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share, because the effect of their inclusion would have been anti-dilutive.
	Options to purchase common stock			1,671,235			—		1,671,235		—
	RSUs			462,060			—		462,060		—
	Total potentially dilutive securities			3,060,301			3,210,126		3,060,301		3,210,126			For the Year		For the Period
	Fair Value Measurements													Ended		October 30,
	The carrying amounts of cash and cash equivalents, accounts payable and accrued expenses, approximate fair value due to the short-term nature of these instruments. Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:													December 31,		2012 (Inception)
		Level 1	Quoted prices in active markets for identical assets or liabilities.											2013		Through
		Level 2	Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.													December 31,
		Level 3	Significant unobservable inputs that cannot be corroborated by market data.													2012
	The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of the liabilities that are measured at fair value on a recurring basis.											Convertible Notes – principal			2,650,858		—
												Convertible Notes – accrued interest			100,227		—
												Consulting Warrant to purchase common stock			278,228		—
			Total			Quoted Prices		Quoted Prices		Significant		Financing Warrant to purchase common stock			220,905		—
						in Active		for Similar		Unobservable		Options to purchase common stock			275,689		—
						Markets for		Assets or		Inputs		Total potentially dilutive securities			3,525,907		—
						Identical		Liabilities in		(Level 3)		Fair Value Measurements
						Assets or		Active				The carrying amounts of cash and cash equivalents, accounts payable and accrued expenses, approximate fair value due to the short-term nature of these instruments.
						Liabilities		Markets				Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:
						(Level 1)		(Level 2)					Level 1	Quoted prices in active markets for identical assets or liabilities.
	Derivative Liabilities:												Level 2	Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.
	December 31, 2013:												Level 3	Significant unobservable inputs that cannot be corroborated by market data.
	Conversion Feature		$	5,573,000		$	—	$	—	$	5,573,000	The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of the assets that are measured at fair value on a recurring basis:
	Financing Warrant			175,000			—		—		175,000
	Consulting Warrant			529,000			—		—		529,000
	Total		$	6,277,000		$	—	$	—	$	6,277,000			Total		Quoted Prices in		Quoted Prices		Significant
	As of September 30, 2014, the Company no longer had financial instruments which were derivative liabilities.															Active Markets		for Similar		Unobservable
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:															for Identical		Assets or		Inputs
																Assets or		Liabilities in		(Level 3)
																Liabilities		Active Markets
			For the													(Level 1)		(Level 2)
			Nine Months									Derivative Liabilities:
			Ended									31-Dec-12		$	—	$	—	$	—	$	—
			September 30,									December 31, 2013:
			2014									Conversion Feature		$	5,573,000	$	—	$	—	$	5,573,000
	Beginning balance		$	6,277,000								Financing Warrant			175,000		—		—		175,000
	Change in fair value of conversion feature and warrants			26,265,177								Consulting Warrant			529,000		—		—		529,000
	Extinguishment of derivative liability upon conversion of Convertible Notes			(26,790,177	)							Total		$	6,277,000	$	—	$	—	$	6,277,000
	Extinguishment of derivative liability upon modification of Financing Warrant			(1,733,000	)							The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:
Extinguishment of derivative liability upon modification of Consulting Warrant			(4,019,000	)
Ending balance		$	—
The conversion feature of the Convertible Notes immediately prior to conversion was measured at fair value using a Monte Carlo simulation (which also represented the intrinsic value of the conversion feature) and was classified within Level 3 of the valuation hierarchy. The warrant liabilities for the Financing Warrant and the Consulting Warrant, immediately prior to modification were measured at fair value using a Monte Carlo simulation and were classified within Level 3 of the valuation hierarchy. The significant assumptions and valuation methods that the Company used to determine fair value and the change in fair value of the Company’s derivative financial instruments are discussed in Note 6 — Private Placement.													For the Year		For the Period
Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Interim Chief Financial Officer determined its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Interim Chief Financial Officer with support from the Company’s consultants and which are approved by the Interim Chief Financial Officer.													Ended		October 30,
Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.													December 31,		2012 (inception)
The Company used a Monte Carlo model to value Level 3 financial liabilities at inception and on subsequent valuation dates, except that the conversion feature of the convertible notes immediately prior to conversion was valued at intrinsic value. This simulation incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as, volatility. The Company also used a binomial simulation and Black-Scholes economic model as supplemental valuation tools in order to validate the reasonableness of the results of the Monte Carlo simulation when measuring the Financing Warrant and the Consulting Warrant.													2013		Through
A significant increase in the volatility or a significant increase in the Company’s stock price, in isolation, would result in a significantly higher fair value measurement. Changes in the values of the derivative liabilities were recorded in Change in Fair Value of Derivative Liabilities within Other Expense (Income) on the Company’s Statements of Operations.															December 31,
As of September 30, 2014, there were no transfers in or out of level 3 from other levels in the fair value hierarchy.															2012
In accordance with the provisions of ASC 815, the Company presented the conversion feature and warrant liabilities at fair value on its balance sheet, with the corresponding changes in fair value recorded in the Company’s statement of operations for the applicable reporting periods.											Beginning balance		$	—	$	—
Management determined that the results of its valuations are reasonable.											Aggregate fair value of conversion feature and warrants upon issuance			6,100,000		—
Recent Accounting Pronouncements											Change in fair value of conversion feature and warrants			177,000		—
In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation.” This ASU removes the definition of a development stage entity from the ASC, thereby removing the financial reporting distinction between development stage entities and other reporting entities from GAAP. In addition, the ASU eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and stockholders’ equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. This ASU is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. Early adoption is permitted. The Company has elected to adopt this ASU effective with the Quarterly Report on Form 10-Q filed on August 14, 2014 and its adoption resulted in the removal of previously required development stage disclosures.											Ending balance		$	6,277,000	$	—
The FASB has issued ASU No. 2014-12, Compensation — Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company has elected to adopt this ASU effective with this Quarterly Report and its adoption is not expected to have a material effect.											The conversion feature of the Convertible Notes was measured at fair value using a Monte Carlo simulation and is classified within Level 3 of the valuation hierarchy. The warrant liabilities for the Financing Warrant and the Consulting Warrant were measured at fair value using a Monte Carlo simulation and are classified within Level 3 of the valuation hierarchy. The significant assumptions and valuation methods that the Company used to determine fair value and the change in fair value of the Company’s derivative financial instruments are discussed in Note 7 — Private Placement.
In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which supersedes the revenue recognition requirements in ASC Topic 605, “Revenue Recognition,” and most industry-specific guidance. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The amendments in the ASU must be applied using one of two retrospective methods and are effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The Company will evaluate the effects, if any, that adoption of this guidance will have on its financial statements.											Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivate liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Chief Financial Officer determined its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Chief Financial Officer with support from the Company’s consultants and which are approved by the Chief Financial Officer.
Management’s Evaluation of Subsequent Events											Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.
The Company evaluates events that have occurred after the balance sheet date of September 30, 2014, through the date which the condensed financial statements are issued. Based upon the review, other than described in Note 10 — Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed financial statements.											The Company uses a Monte Carlo model to value Level 3 financial liabilities at inception and on subsequent valuation dates. This simulation incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as, volatility. The Company also used a binomial simulation and Black-Scholes economic model as supplemental valuation tools in order to validate the reasonableness of the results of the Monte Carlo simulation when measuring the Financing Warrant and the Consulting Warrant.
											A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation, would result in a significantly lower fair value measurement. Changes in the values of the derivative liabilities are recorded in Change in Fair Value of Derivative Liabilities within Other Expense (Income) on the Company’s Statements of Operations.
											As of December 31, 2013 and 2012, there were no transfers in or out of level 3 from other levels in the fair value hierarchy.
											In accordance with the provisions of ASC 815, the Company presented the conversion feature and warrant liabilities at fair value on its balance sheet, with the corresponding changes in fair value recorded in the Company’s statement of operations for the applicable reporting periods.
											The fair value of the Company’s common stock was determined by a third party valuation consultant, and was derived from the valuation of the Company using a methodology which back-solved to the fair value of the common stock on May 16, 2013 and December 31, 2013, based upon the Company’s capitalization, existing dilutive securities and the proceeds received from the issuance of the Convertible Notes. For the purposes of this back-solve computation, management assumed that the Convertible Notes would convert at $2.07 per share (the floor level), and that the Financing Warrant would have an exercise price of $2.49 per common share or, 120% of the exercise price of the Convertible Notes.
											Management determined that the results of its valuations are reasonable.
											Convertible Instruments
											The Company accounts for hybrid contracts that feature conversion options in accordance with ASC 815 “Derivatives and Hedging Activities,” (“ASC 815”) and ASC 480 “Distinguishing Liabilities from Equity” (“ASC 480”), which require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria includes circumstances in which (i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments which have been determined to be free standing derivative financial instruments (when the Company has determined that the embedded conversion options should be bifurcated from their host instruments) in accordance with ASC 815. Under ASC 815, a portion of the proceeds received upon the issuance of the hybrid contract are allocated to the fair value of the derivative. The derivative is subsequently marked to market at each reporting date based on current fair value, with the changes in fair value reported in results of operations.
											Conversion options that contain variable settlement features such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract generally result in their bifurcation from the host instrument.
											The Company accounts for convertible debt instruments, when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, in accordance with ASC 470-20 “Debt with Conversion and Other Options”. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt.
											Common Stock Purchase Warrants and Other Derivative Financial Instruments
											The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provides a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company’s own stock as defined in ASC 815-40 “Contracts in Entity’s Own Equity” (“ASC 815-40”). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of common stock purchase warrants and other free standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities or equity is required.
											Management’s Evaluation of Subsequent Events
											The Company evaluates events that have occurred after the balance sheet date of December 31, 2013, through the date which the financial statements were available to be issued. Based upon the review, other than described in Note 12 — Subsequent Event, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

Property_and_Equipment

Property and Equipment	9 Months Ended							12 Months Ended
	Sep. 30, 2014							Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'							'
Property, Plant and Equipment Disclosure [Text Block]	'							'
	Note 4 — Property and Equipment							Note 5 — Property and Equipment
	Property and equipment are as follows:							Property and equipment are as follows:
		As of							As of December 31,
		September 30,			December 31,				2013			2012
		2014			2013			Computer software	$	114,876			—
	Computer software	$	369,453		$	114,876		Computer hardware		28,779			—
	Computer hardware		492,852			36,240		Furniture and fixtures		35,919			—
	Furniture and fixtures		277,679			28,458		Leasehold improvements		14,755			—
	Leasehold improvements		341,104			14,755				194,329			—
			1,481,088			194,329		Less – Accumulated depreciation		(4,717	)		—
	Less – Accumulated depreciation		(182,194	)		(4,717	)	Total property and equipment, net	$	189,612			—
	Total property and equipment, net	$	1,298,894		$	189,612		Total depreciation and amortization expense of the Company’s property and equipment was $4,717, $0 and $4,717, for the year ended December 31, 2013, for the period October 30, 2012 (inception) through December 31, 2012 and for the period October 30, 2012 (inception) through December 31, 2013, respectively. For the year ended December 31, 2013, for the period October 30, 2012 (inception) through December 31, 2012 and for the period October 30, 2012 (inception) through December 31, 2013, depreciation and amortization charged to general and administrative expenses was $3,102, $0 and $3,102 and charged to research and development expense was $1,615, $0 and $1,615, respectively.
	Total depreciation and amortization expense of the Company’s property and equipment was $142,093 and $833 for the three months ended September 30, 2014 and 2013, and $196,898 and $880, for the nine months ended September 30, 2014 and 2013, respectively, reflected within general and administrative expense.

Accrued_Expenses_and_Other_Cur

Accrued Expenses and Other Current Liabilities	9 Months Ended					12 Months Ended
	Sep. 30, 2014					Dec. 31, 2013
Payables and Accruals [Abstract]	'					'
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	'					'
	Note 5 — Accrued Expenses and Other Current Liabilities					Note 6 — Accrued Expenses and Other Current Liabilities
	Accrued expenses consist of the following:					Accrued expenses consist of the following:
		As of					As of December 31,
		September 30,		December 31,			2013		2012
		2014		2013		Accrued interest payable	$	207,945	$	—
	Accrued interest payable	$	—	$	207,945	Accrued compensation		19,894		—
	Accrued compensation		215,159		19,894	Other accrued expenses		15,784		10,406
	Other accrued expenses		241,104		15,784	Total	$	243,623	$	10,406
	Total	$	456,263	$	243,623

Private_Placement

Private Placement	9 Months Ended													12 Months Ended
	Sep. 30, 2014													Dec. 31, 2013
Private Placement [Abstract]	'													'
Private Placement [Text Block]	'													'
	Note 6 — Private Placement													Note 7 — Private Placement
	Senior Secured Convertible Notes													Senior Secured Convertible Notes
	On May 16, 2013, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors (the “Investors”), pursuant to which the Company sold an aggregate of $5,500,009 principal amount of senior secured convertible notes (the “Convertible Notes”). In connection with the sale of the Convertible Notes (the “Bridge Financing”), the Company entered into a registration rights agreement (the “Registration Rights Agreement”) and a security agreement (the “Security Agreement”) with the Investors. The closing of the Bridge Financing was completed on May 16, 2013. The Convertible Notes bore interest at 6% per annum and would have matured on August 16, 2014.													On May 16, 2013, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors (the “Investors”), pursuant to which the Company sold an aggregate of (i) $5,500,009 principal amount of senior secured convertible notes (the “Convertible Notes”). In connection with the sale of the Convertible Notes (the “Bridge Financing”), the Company entered into a registration rights agreement (the “Registration Rights Agreement”) and a security agreement (the “Security Agreement”) with the Investors. The closing of the Bridge Financing was completed on May 16, 2013. The Convertible Notes bear interest at 6% per annum and mature on August 16, 2014.
	In connection with the funding of the IPO, on April 2, 2014, the principal and interest due under the Convertible Notes of $5,500,009 and $290,219, were converted into 1,833,336 and 96,792 shares, respectively, of common stock. The purchasers of the Convertible Notes are subject to lock-up requirements for periods that expire October 2, 2014. The security agreement terminated on April 2, 2014, upon the conversion of the Convertible Notes.													The principal and interest of the Convertible Notes are convertible into the Company’s common stock at a conversion price between $2.07 and $4.14 per share depending on the facts and circumstances at the time of the conversion (see below). Upon issuance, the Convertible Notes bear simple interest at 6% per annum, and upon the occurrence of any specified event of default, the Convertible Notes would bear interest at 12% per annum. The Convertible Notes may be prepaid or converted into Common Stock with consent of the holder or the holders of a majority of the principal then outstanding under all the Convertible Notes (the “Required Holders”) and upon certain events constituting a change in control of the Company. The Convertible Notes are required to be converted upon a qualifying initial public offering of at least $10,000,000 (the “IPO”), if any, in which case the conversion price is to be equal to 50% of the price to the public in such offering (but not more than $4.14 or less than $2.07 per share). A Convertible Note may also be converted in certain circumstances at the election of the holder of the Convertible Note in connection with a financing that is not an initial public offering, in which case the conversion price is to be equal to 50% of the price paid by the investors in such financing (but not more than $4.14 or less than $2.07 per share). In the event of an optional conversion by the holder of a Convertible Note during a continuing event of default, the conversion price would be $2.07; otherwise the optional conversion price would be $4.14. The conversion price under the Convertible Notes is further subject to adjustment in the event of stock splits, combinations or the like and upon certain other events, all as provided in the Convertible Notes.
	Accounting for the Senior Secured Convertible Notes													The aggregate amount of accrued interest on the Convertible Notes was $207,945 and $0 as of December 31, 2013 and December 31, 2012, respectively. As of December 31, 2013, the principal and accrued interest on the Convertible Notes were convertible into 2,650,858 and 100,227 shares of the Company’s common stock, respectively, assuming a conversion price of $2.07 per share.
	Pursuant to the terms of the Convertible Notes, the conversion price was subject to adjustment in the event of an IPO, other financing and upon certain other events. The embedded conversion feature was not clearly and closely related to the host instrument and was bifurcated from the host Convertible Notes as a derivative, principally because the instrument’s variable exercise price terms would not qualify as being indexed to the Company’s own common stock. Accordingly, through April 1, 2014, this conversion feature instrument was classified as a derivative liability. Derivative liabilities are initially recorded at fair value and are then re-valued at each reporting date, with changes in fair value recognized in earnings during the reporting period.													Accounting for the Senior Secured Convertible Notes
	The Company calculated the fair value of the embedded conversion feature of the Convertible Notes at April 2, 2014 at the conversion features’ fair value, with the observable assumptions as provided in the table below.													Pursuant to the terms of the Convertible Notes, the conversion price is subject to adjustment in the event of an IPO, other financing and upon certain other events. The embedded conversion feature was not clearly and closely related to the host instrument and was bifurcated from the host Convertible Notes as a derivative, principally because the instrument’s variable exercise price terms would not qualify as being indexed to the Company’s own common stock. Accordingly, this conversion feature instrument has been classified as a derivative liability in the accompanying balance sheet as of December 31, 2013. Derivative liabilities are initially recorded at fair value and are then re-valued at each reporting date, with changes in fair value recognized in earnings during the reporting period.
														The Company determined that the initial fair value of the embedded conversion option was $5,376,000. From the gross proceeds upon the issuance of the Convertible Notes of $5,500,009, the Company deducted in full the fair value of the embedded conversion feature of $5,376,000 as a debt discount, as shown below. The debt discount is being amortized under the effective interest method over the term of the Convertible Notes.
		As of
		2-Apr-14												Face value of the Convertible Notes	$	5,500,009
	Stock price on valuation date	$	13.88											Discount-fair value of embedded conversion feature		(5,376,000	)
	Conversion price	$	3											Proceeds attributable to the Convertible Notes	$	124,009
	Fair value	$	26,790,177											The Company calculated the fair value of the embedded conversion feature of the Convertible Notes using a Monte Carlo simulation, with the observable assumptions as provided in the table below. The significant unobservable inputs used in the fair value measurement of the reporting entity’s embedded conversion feature are expected stock prices, levels of trading and liquidity of the Company stock. Significant increases in the expected stock prices and expected liquidity would result in a significantly higher fair value measurement. Significant increases in either the probability or severity of default of the host instrument would result in a significantly lower fair value measurement.
	The amortization of debt discount related to the Convertible Notes was $0 and $206,370, respectively for the three months ended September 30, 2014 and 2013, and $964,851 and $262,506, respectively, for the nine months ended September 30, 2014 and 2013. During the three months ended September 30, 2014 and 2013, the Company recorded an increase of $0 and $90,000, respectively, and during the nine months ended September 30, 2014 and 2013, the Company recorded an increase of $21,217,177 and $106,000, respectively, in the fair value of the derivative liability for the conversion feature of the Convertible Notes, which was recorded as a change in the fair value of derivative liabilities within the condensed statement of operations. On April 2, 2014, upon the consummation of the IPO, the Convertible Notes and Accrued Interest were converted to 1,833,336 and 96,792 shares, respectively, of the Company’s common stock. This conversion was accounted for as an extinguishment. Accordingly, on April 2, 2014, the Company recorded a gain of $2,084,368 upon the extinguishment of the Convertible Notes, accrued interest, and the related derivative liability. Thereupon, the 1,930,128 shares of common stock were issued and were recorded at their aggregate fair value of $26,790,177.
	Placement Agent Agreement
	On January 23, 2013, the Company entered into an agreement (the “Placement Agent Agreement”) with MDB Capital Group, Inc. (“MDB”), pursuant to which the Company appointed MDB to act as the Company’s placement agent in connection with the sale of the Company’s securities (“Offering or Offerings”). Specifically, MDB was the placement agent in connection with the sale of its Convertible Notes.														As of
	In connection with the sale of the Convertible Notes, the Company paid MDB a cash fee of $538,393 and sold to MDB for $1,000 in cash, a warrant issued on May 16, 2013 (the “Financing Warrant”) to purchase shares of the Company’s common stock. The Financing Warrant was fully vested upon issuance, has a term of five years and may not be exercised until six months after the consummation of a qualifying firm commitment underwritten initial public offering. Pursuant to the terms of the Financing Warrant, the aggregate exercise price is fixed at $550,000, with the per share exercise price being $3.60 based upon 120% of the conversion price of $3.00 of the Convertible Notes upon the consummation of the IPO. As of September 30, 2014, the Financing Warrant was exercisable into 152,778 shares of the Company’s common stock, assuming an exercise price of $3.60 per share (or 120% of the Convertible Notes conversion price of $3.00 per share).														16-May-13			31-Dec-13
	As originally executed and through June 24, 2014, in the event of a non-liquid exit transaction, as defined in the Financing Warrant agreement, the holder of the Financing Warrant could have put the Financing Warrant back to the Company for a cash settlement at a fair value amount that would be determined by appraisal and agreed to by both parties (the “Financing Warrant Put”). On June 25, 2014, the Financing Warrant was modified to remove the Financing Warrant put feature.													Stock price on valuation date	$	1.68		$	1.68
	MDB shall have certain registration rights with respect to the common stock issued upon exercise of the Financing Warrant, including a one-time demand registration right with respect to such common stock.													Conversion price		2.07			2.07
	Consulting Agreement													Term (years)		1.25			0.26
	On January 23, 2013, the Company entered into a consulting agreement with MDB (the “Consulting Agreement”), pursuant to which MDB agreed to provide financial, strategic and intellectual property advisory services. The Consulting Agreement had an initial term of 180 days, and was renewed automatically upon the expiration of its initial term, after which it will continue in effect until it is terminated by either party with 30 days written notice to the other party. On July 11, 2014, the Company provided notice to MDB of its termination of the Consulting Agreement.													Expected volatility		60	%		60	%
	As consideration for services provided under the Consulting Agreement prior to May 16, 2013, the Company sold to MDB for $1,500 in cash, a warrant (the “Consulting Warrant”) for the purchase of an aggregate of 278,228 shares of the Company’s common stock. The Consulting Warrant was fully vested upon issuance, has a term of five years, an exercise price of $0.04 per share and may not be exercised until six months after the consummation of the IPO. The Consulting Warrant may be exercised on a cashless basis. As originally executed and through June 24, 2014, in the event of a non-liquid exit transaction, as defined in the Consulting Warrant, the holder of the Consulting Warrant could have put the Consulting Warrant back to the Company for a cash settlement at a fair value amount that would be determined by appraisal and agreed to by both parties (the “Consulting Warrant Put”). On June 25, 2014, the Consulting Warrant was modified to remove the Consulting Warrant put feature.													Dividend yield		0	%		0	%
	MDB shall have certain registration rights with respect to the common stock issued upon exercise of the Consulting Warrant, including a one-time demand registration right with respect to such common stock.													Weighted average risk-free interest rate		0.79	%		1.75	%
	Accounting for the Financing Warrant and the Consulting Warrant													Trials		20,000			20,000
	The Company determined that due to their cash settlement features, as originally issued, both the Financing Warrant and the Consulting Warrant qualified as derivative instruments. Accordingly upon issuance, these instruments were classified as derivative liabilities. Derivative liabilities are initially recorded at fair value and are then re-valued at each reporting date, with changes in fair value recognized in earnings during the reporting period. Effective on June 25, 2014, upon the removal of the cash settlement put features within the Financing Warrant and the Consulting Warrant, (as discussed above), each of the Consulting Warrant and the Financing Warrant no longer qualified as derivative instruments. Accordingly, on June 25, 2014, after first recording a mark-to-market adjustment to fair value, the aggregate fair value of $5,752,000 for both warrants was credited to additional paid in capital.													Aggregate fair value	$	5,376,000		$	5,573,000
	The Company calculated the fair value of the Financing Warrant and the Consulting Warrant using a Monte Carlo simulation, with the observable assumptions as provided in the table below. The significant unobservable inputs used in the fair value measurement of the reporting entity’s Financing Warrant and the Consulting Warrant are expected stock prices, levels of trading and liquidity of the Company’s common stock. Significant increases in the expected stock prices and expected liquidity would result in a significantly higher fair value measurement. Significant increases in either the probability or severity of default of the host instrument would result in a significantly lower fair value measurement.													The amortization of debt discount related to the Convertible Notes was $705,289, $0 and $705,289, respectively, for the year ended December 31, 2013, for the period October 30, 2012 (inception) through December 31, 2012, and for the period October 30, 2012 (inception) through December 31, 2013. As of December 31, 2013, the debt discount will be amortized over a remaining period of 0.6 years. The derivative liability related to the embedded conversion feature is revalued at each reporting period. During the year ended December 31, 2013, for the period October 30, 2012 (inception) through December 31, 2012 and for the period October 30, 2012 (inception) through December 31, 2013, the Company recorded an increase of $197,000, $0 and $197,000, respectively, in the fair value of the derivative liability for the conversion feature of the Convertible Notes, which was recorded as a change in the fair value of derivative liabilities within the statement of operations.
	Provided below are the principal assumptions used in the measurement of the fair values of the Financing Warrant and the Consulting Warrant as of June 24, 2014 and December 31, 2013.													Placement Agent Agreement
														On January 23, 2013, the Company entered into an agreement (the “Placement Agent Agreement”) with MDB Capital Group, Inc. (“MDB”), pursuant to which the Company appointed MDB to act as the Company’s placement agent in connection with the sale of the Company’s securities (“Offering or Offerings”). Specifically, MDB was the placement agent in connection with the sale of its Convertible Notes. The Placement Agent Agreement had an initial term of 180 days, and was renewed automatically upon the expiration of its initial term, after which it will continue in effect until it is terminated by either party with 60 days written notice to the other party.
														In connection with the sale of the Convertible Notes, the Company paid MDB a cash fee of $538,393 and sold to MDB for $1,000 in cash, a warrant issued on May 16, 2013 (the “Financing Warrant”) to purchase shares of the Company’s common stock. The Financing Warrant was fully vested upon issuance, has a term of five years and may not be exercised until six months after the consummation of a qualifying firm commitment underwritten initial public offering. Pursuant to the terms of the Financing Warrant, the aggregate exercise price is fixed at $550,000, with the per share exercise price determined based upon 120% of the conversion price of the Convertible Notes upon the consummation of the IPO, or upon other events under which the Convertible Notes may convert. As of December 31, 2013, the Financing Warrant is exercisable into 220,905 shares of the Company’s common stock, respectively, assuming an exercise price of $2.49 per share (or 120% of the Convertible Notes conversion price of $2.07 per share).
		As of June 24, 2014						As of December 31, 2013						In addition, in the event of a non-liquid exit transaction, as defined in the Financing Warrant agreement, the holder of the Financing Warrant may put the Financing Warrant back to the Company for a cash settlement at a fair value amount to be determined by appraisal and agreed to by both parties.
		Financing			Consulting			Financing			Consulting			MDB shall have certain registration rights with respect to the common stock issued upon exercise of the Financing Warrant, including a one-time demand registration right with respect to such common stock.
		Warrant			Warrant			Warrant			Warrant			Consulting Agreement
	Stock price on valuation date	$	14.69		$	14.69		$	1.68		$	1.68		On January 23, 2013, the Company entered into a consulting agreement with MDB (the “Consulting Agreement”), pursuant to which MDB agreed to provide financial, strategic and intellectual property advisory services. The Consulting Agreement had an initial term of 180 days, and was renewed automatically upon the expiration of its initial term, after which it will continue in effect until it is terminated by either party with 30 days written notice to the other party.
	Exercise price	$	3.6		$	0.04		$	2.49		$	0.04		As consideration for services provided under the Consulting Agreement prior to May 16, 2013, the Company sold to MDB for $1,500 in cash, a warrant (the “Consulting Warrant”) for the purchase of an aggregate of 278,228 shares of the Company’s common stock.
	Term (years)		3.89			3.89			4.38			4.38		The Consulting Warrant was fully vested upon issuance, has a term of five years, an exercise price of $0.04 per share and may not be exercised until six months after the consummation of a qualifying firm commitment underwritten initial public offering. The Consulting Warrant may be exercised on a cashless basis. In addition, in the event of a non-liquid exit transaction, as defined in the Consulting Warrant, the holder of the Consulting Warrant may put the Consulting Warrant back to the Company for a cash settlement at a fair value amount to be determined by appraisal and agreed to by both parties.
	Expected volatility		60	%		60	%		60	%		60	%	MDB shall have certain registration rights with respect to the common stock issued upon exercise of the Consulting Warrant, including a one-time demand registration right with respect to such common stock.
	Dividend yield		0	%		0	%		0	%		0	%	Accounting for the Financing Warrant and the Consulting Warrant
	Weighted average risk-free interest rate		1.33	%		1.33	%		1.75	%		1.75	%	The Company determined, based upon authoritative guidance, that both the Financing Warrant and the Consulting Warrant qualified as derivative instruments. Accordingly, these instruments have been classified as derivative liabilities in the accompanying balance sheet as of December 31, 2013. Derivative liabilities are initially recorded at fair value and are then re-valued at each reporting date, with changes in fair value recognized in earnings during the reporting period.
	Number of warrants		152,778			278,228			220,905			278,228		The Company calculated the fair value of the Financing Warrant and the Consulting Warrant using a Monte Carlo simulation, with the observable assumptions as provided in the table below. The significant unobservable inputs used in the fair value measurement of the reporting entity’s Financing Warrant and the Consulting Warrant are expected stock prices, levels of trading and liquidity of the Company’s common stock. Significant increases in the expected stock prices and expected liquidity would result in a significantly higher fair value measurement. Significant increases in either the probability or severity of default of the host instrument would result in a significantly lower fair value measurement.
	Number of trials		20,000			20,000			20,000			20,000		Provided below are the principal assumptions used in the measurement of the fair values of the Financings Warrant and the Consulting Warrant as of May 16, 2013 and December 31, 2013.
	Aggregate fair value	$	1,733,000		$	4,019,000		$	175,000		$	529,000
	The initial fair value of the Financing Warrant was $186,500 and was accounted for as derivative issuance expense and along with the other derivative issuance expenses (see below), was expensed upon the issuance of the Convertible Notes. The initial fair value of the Consulting Warrant was $537,500, and was expensed immediately as a consulting fee and was recorded within general and administrative expenses in the condensed statement of operations for the year ended December 31, 2013. During the three months ended September 30, 2014 and 2013, the Company recorded an aggregate decrease of $0 and $1,000, respectively, and during the nine months ended September 30, 2014 and 2013, the Company recorded increases of $5,048,000 and $5,500, respectively, in the fair values of the derivative liability of the Financing Warrant and the Consulting Warrant, which was recorded as a change in the fair value of derivative liabilities within the condensed statement of operations.
	Patent Assignment														As of May 16, 2012						As of December 31, 2013
	On May 16, 2013, the Company entered into a patent assignment and Security Agreement with the Investors, in order to grant a continuing security interest in the patents included as collateral pledged in connection with the Convertible Notes. The security interest in the Company’s patents terminated on April 2, 2014, in connection with the conversion of the Convertible Notes.														Financing			Consulting			Financing			Consulting
															Warrant			Warrant			Warrant			Warrant
														Stock price on valuation date	$	1.68		$	1.68		$	1.68		$	1.68
														Exercise price	$	2.49		$	0.04		$	2.49		$	0.04
														Term (years)		5			5			4.38			4.38
														Expected volatility		60	%		60	%		60	%		60	%
														Dividend yield		0	%		0	%		0	%		0	%
														Weighted average risk-free interest rate		0.79	%		0.79	%		1.75	%		1.75	%
														Number of warrants		220,905			278,228			220,905			278,228
														Number of trials		20,000			20,000			20,000			20,000
														Aggregate fair value	$	186,500		$	537,500		$	175,000		$	529,000
														The initial fair value of the Financing Warrant was $186,500 and was accounted for as derivative issuance expense and along with the other derivative issuance expenses (see below), was expensed upon the issuance of the Convertible Notes. The initial fair value of the Consulting Warrant was $537,500, and was expensed immediately as a consulting fee and was recorded within general and administrative expenses in the statement of operations for the year ended December 31, 2013. During the year ended of December 31, 2013, the Company recorded an aggregate decrease of $20,000 in the fair value of the derivative liability for the Financing Warrant and the Consulting Warrant, which was recorded as a change in the fair value of derivative liabilities within the statement of operations.
														Derivative Issuance Expenses
														Derivative issuance expenses incurred in connection with the Private Placement are shown below and were expensed upon the issuance of the Convertible Notes, as substantially all the value was attributable to the derivative instruments.
															For the Year
															Ended
															December 31,
															2013
														Fair value of Financing Warrant	$	186,500
														Cash placement agent fee		538,393
													Legal and other expenses		162,169
													Total	$	887,062
													Patent Assignment
													On May 16, 2013, the Company entered into a patent assignment and Security Agreement with the Investors, in order to grant a continuing security interest in the patents included as collateral pledged in connection with the Convertible Notes.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'	'
Commitments and Contingencies Disclosure [Text Block]	'	'
	Note 7 — Commitments and Contingencies	Note 8 — Commitments and Contingencies
	Investor Relations Agreement	Consulting Agreements
	Effective January 13, 2014, the Company entered into an agreement with a vendor (“IR Firm”) to provide investor relations services to the Company. Pursuant to the agreement, in addition to monthly cash compensation of $8,000 per month, on March 27, 2014 the Company issued to the IR firm a consulting warrant (“IR Consulting Warrant”) for the purchase of 36,000 shares of common stock. The IR Consulting Warrant has a strike price of $7.80, representing 130% of the IPO price. The IR Consulting Warrant has an initial catch up vesting equivalent to 3,000 shares per month of service, partial months to be prorated on a thirty (30) day basis, from the effective date of this agreement until March 27, 2014. Thereafter, the IR Consulting Warrant will vest at a rate of 3,000 shares per month of service. In addition, the Company agreed to issue to the IR Firm incentive warrants (“IR Incentive Warrants”) to purchase 5,000 shares of common stock with a strike price of $7.80 in the event of and upon each qualified investor, institutional or brokerage firm purchasing at least $250,000 in value of the Company’s common shares at the IPO price or greater in the open market on or after the 46th day following March 27, 2014. All IR Incentive Warrants granted during a six month period will collectively vest at each six month anniversary. Both the IR Consulting Warrant and IR Incentive Warrants will have an expiration date four (4) years from the grant date. The shares underlying both the IR Consulting Warrant and the IR Incentive Warrants will either be registered at the next available opportunity or the warrants will include a cashless exercise provision.	On May 14, 2013, the Company entered into a consulting agreement with Cheryl Sanchez, the sister of one of the directors and stockholders of the Company, for Ms. Sanchez to provide finance, accounting and other advisory services (“Finance Consulting Agreement”). Ms. Sanchez was paid at a rate of $21,550 per month. In connection with the execution of the Finance Consulting Agreement, Ms. Sanchez purchased for $35,464 in cash, 88,882 shares of the Company’s common stock, under the Company’s 2013 Stock Plan (See Note 10 —  Stock Based Compensation). The Company’s board of directors determined that the purchase price of $0.40 per share represented the fair value of these shares upon issuance, and further concluded that no compensation was deemed to be awarded to Ms. Sanchez in connection with this share issuance. The Finance Consulting Agreement was terminated effective November 30, 2013. In connection with the termination of the Finance Consulting Agreement, the Company repurchased for $29,533 a total of 74,068 shares of restricted common stock from Ms. Sanchez.
	As of September 30, 2014, 25,800 shares under the IR Consulting Warrant were vested, and no IR Incentive Warrants have been granted.	Operating Lease
	For the three and nine months ended September 30, 2014, the Company incurred stock-based compensation expense of $39,410 and $198,983, respectively, in connection with the IR Consulting warrant, which was included in general and administrative expense.	On October 4, 2013, the Company executed an eight month lease for 3,562 square feet of office space in Pleasanton California from an affiliate of Greg Brewer, one of the Company’s directors. The base rent is $6,055 per month. The Company has the right to terminate the lease upon 30 days written notice.
	Operating Leases	Employment Agreements
	On October 4, 2013, the Company executed a lease expiring on June 4, 2014 for 3,562 square feet of office space in Pleasanton, California from an affiliate of Greg Brewer, one of the Company’s former directors, with a base rent of $6,055 per month. The lease was amended and extended to September 30, 2014 with a base monthly rent of $8,548 for the period June 5, 2014 through September 30, 2014.	The following is a summary of the employment arrangements with our executive officers as currently in effect.
	On September 10, 2014, the Company entered into a Lease Agreement (the “Lease”) with Balzer Family Investments, L.P. (the “Landlord”) related to space located at Northpointe Business Center, 3590 North First Street, San Jose, California. The initial term of the lease is 60 months, with initial monthly base rent of $36,720. On October 1, 2014, the Company relocated its headquarters to this new location. The Company issued to the Landlord 41,563 shares of the Company’s common stock valued at $500,000, of which $400,000 will be applied to reduce the Company’s monthly base rent obligation by $6,732 per month and of which $100,000 was for certain tenant improvements. The Company recorded $400,000 as prepaid rent on its balance sheet, which will be amortized over the term of the lease and recorded $100,000 as leasehold improvements.	Stephen Rizzone
		The Company entered into an employment agreement with Stephen Rizzone, the Company’s President, Chief Executive Officer and chairman of the board of directors, effective October 1, 2013. The employment agreement has no specific term and constitutes at-will employment. Mr. Rizzone’s current annual base salary is $150,000, although his annual base salary will increase to $300,000 immediately following our initial public offering, and he is eligible for up to five annual cash bonuses of up to $30,000 each (one each with respect to our fiscal quarters and one with respect to our fiscal year) based upon achievement of performance-based objectives established by our board of directors. Pursuant to Mr. Rizzone’s employment agreement, he was granted a ten year option to purchase 275,689 shares of common stock on December 12, 2013 under our 2013 Equity Incentive Plan that vests over four years in 48 equal monthly installments. Mr. Rizzone’s employment agreement provides that upon the consummation of our initial public offering he will receive an additional option award so that together with Mr. Rizzone’s December 2013 option award the two option awards combined represent six percent (6%) of the Company’s outstanding shares on a fully-diluted basis. The second option award, if issued, will vest over the same vesting schedule as Mr. Rizzone’s December, 2013 option award.
		If Mr. Rizzone’s employment is terminated due to his death or disability, by the Company without cause or if Mr. Rizzone resigns for good reason, Mr. Rizzone will be entitled to receive (i) one year of his base salary at the rate then in effect, (ii) five performance bonuses (each equal to the average of the performance bonus paid with respect to the two fiscal quarters, or the fiscal quarter-end and fiscal year-end, as applicable, immediately preceding Mr. Rizzone’s termination or resignation) (iii) reimbursement of Mr. Rizzone’s cost of COBRA coverage for one year, and (iv) twenty-five percent (25%) of the options to purchase shares of common stock subject to Mr. Rizzone’s option awards described above will vest immediately and become exercisable, and, along with any previously vested and unexercised options, may be exercised by Mr. Rizzone within one year following his termination or resignation. However, if a Liquidation Event (as defined below) shall occur within one year of Mr. Rizzone’s termination without cause or his resignation for good reason, all of Mr. Rizzone’s option awards described above will vest immediately and become exercisable. Mr. Rizzone’s employment agreement provides that if the Company experiences a Liquidation Event (as defined below), Mr. Rizzone’s employment with the Company will be terminated and the Company will enter into a consulting agreement with Mr. Rizzone that entitles him to the following during its term: (i) continued payment of Mr. Rizzone’s base salary at the rate then in effect, (ii) continued payment of Mr. Rizzone’s performance bonuses described above, and (iii) continued payment of benefits that are substantially similar to those of the Company’s other senior executive officers, and (iv) continuation of the vesting period of the option awards described above. The term of the consulting agreement between the Company and Mr. Rizzone shall expire on the later of two years from the date of the Liquidation event or October 1, 2017. For purposes of Mr. Rizzone’s employment agreement, a Liquidation Event means a merger, acquisition, consolidation or other transaction (other than an equity financing) following which our stockholders prior to such transaction hold less than fifty percent (50%) of our outstanding voting securities of the acquiring or surviving entity, or a sale, license or transfer of all or substantially all of our assets.
		If Mr. Rizzone resigns without good reason, he will be entitled to his base salary at the rate then in effect up to and through the effective date of his resignation, along with any unreimbursed reasonable, out-of-pocket business expenses incurred by Mr. Rizzone in the performance of his duties.
		Mr. Rizzone is also eligible to receive benefits that are substantially similar to those of the Company’s other senior executive officers. Mr. Rizzone is subject to certain restrictive covenants, including non-solicitation of employees, consultants and customers and non-competition each for a period one year following termination of his employment with the Company.
		Michael Leabman
		We entered into an employment agreement with Michael Leabman, the Company’s Chief Technology Officer, effective October 1, 2013. The employment agreement has no specific term and constitutes at-will employment. Mr. Leabman’s current annual base salary is $250,000, and he is eligible for an annual performance based bonus award of up to twenty percent (20%) of his base salary based upon achievement of performance-based objectives established by our Chief Executive Officer and board of directors. Pursuant to Mr. Leabman’s employment agreement, he is entitled to a ten year option to purchase 57,644 shares of common stock under our 2013 Equity Incentive Plan that vests  3/48th on the date of grant, and will vest  1/48th monthly over the following 45 months. Mr. Leabman’s employment agreement provides that upon the consummation of our initial public offering, if Mr. Leabman’s option award plus any Company securities he currently owns represent less than three percent (3%) of the Company’s outstanding shares on a fully-diluted basis, he shall be entitled to a second option award which will entitle him to purchase that number of shares of our common stock such that the two option awards combined plus any Company securities he currently owns represent three percent (3%) of the Company’s outstanding shares on a fully-diluted basis. The second option award, if issued, will vest over the same vesting schedule as Mr. Leabman’s initial option award.
		If Mr. Leabman’s employment is terminated due to his death or disability, by the Company without cause or if Mr. Leabman resigns for good reason, Mr. Leabman will be entitled to receive (i) one year of his base salary at the rate then in effect, (ii) a performance bonuses each equal to the total performance bonuses paid to Mr. Leabman in the calendar year immediately preceding Mr. Leabman’s termination or resignation (iii) reimbursement of Mr. Leabman’s cost of COBRA coverage for one year, and (iv) twenty-five percent (25%) of the options to purchase shares of common stock subject to Mr. Leabman’s option awards described above will vest immediately and become exercisable, and, along with any previously vested and unexercised options, may be exercised by Mr. Leabman within one year following his termination or resignation. However, if a Liquidation Event (as defined below) shall occur within one year of Mr. Leabman’s termination without cause or his resignation for good reason, all of Mr. Leabman’s options to purchase shares of common stock pursuant to the option awards described above will vest immediately and become exercisable.
		In addition to those benefits described above, if Mr. Leabman’s employment is terminated by the Company without cause or he resigns for Good Reason within 18 months of a Liquidation Event (as defined below), all of Mr. Leabman’s options to purchase shares of common stock pursuant to the option awards described above will vest immediately and become exercisable. For purposes of Mr. Leabman’s employment agreement, a Liquidation Event has the same meaning as in Mr. Rizzone’s employment agreement.
		If Mr. Leabman resigns without good reason, he will be entitled to his base salary at the rate then in effect up to and through the effective date of his resignation, along with any unreimbursed reasonable, out-of-pocket business expenses incurred by Mr. Leabman in the performance of his duties.
		Mr. Leabman is also eligible to receive benefits that are substantially similar to those of the Company’s other senior executive officers. Mr. Leabman is subject to certain restrictive covenants, including non-solicitation of employees, consultants and customers and non-competition each for a period one year following termination of his employment with the Company.

Stockholders_Equity_Deficit

Stockholders' Equity (Deficit)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Stockholders Equity Note [Abstract]	'	'
Stockholders Equity Note Disclosure [Text Block]	'	'
	Note 8 — Stockholders’ Equity (Deficit)	Note 9 — Stockholders’ Deficiency
	Authorized Capital	Authorized Capital
	The holders of the Company’s common stock are entitled to one vote per share. Holders of common stock are entitled to receive ratably such dividends, if any, as may be declared by the board of directors out of legally available funds. Upon the liquidation, dissolution or winding up of the Company, holders of common stock are entitled to share ratably in all assets of the Company that are legally available for distribution.	The holders of the Company’s common stock are entitled to one vote per share. Holders of common stock are entitled to receive ratably such dividends, if any, as may be declared by the board of directors out of legally available funds. Upon the liquidation, dissolution or winding up of the Company, holders of common stock are entitled to share ratably in all assets of the Company that are legally available for distribution.
	Amendment to Certificate of Incorporation	Series AA Preferred Stock
	On March 26, 2014, the Company’s board of directors and stockholders approved the Second Amended and Restated Certificate of Incorporation which increased the authorized shares to 60,000,000 of which 10,000,000 shares are designated as preferred stock. In addition, a special meeting of stockholders can only be called by the Chairman, Chief Executive Officer, President or the majority of the board of directors and shall be limited to matters relating to the purpose or purposes stated in the notice of meeting. Any actions required, as a result of a special stockholder meeting, can only be taken upon the vote of the stockholders and not by written consent. The stockholders empowered the board of directors at any time prior to the effectiveness of the filing of this Second Amendment and Restated Certificate to abandon the proposed amendment.	During the period from October 30, 2012 (inception) through May 9, 2013, the Company was authorized to issue shares of its Series AA Preferred Stock. The Series AA Preferred Stock ranked senior to the Company’s common stock. The Series AA Preferred Stock was subordinate and ranked junior to all indebtedness of the Company. No shares of the Series AA Preferred Stock were ever issued.
	Initial Public Offering	Common Stock Issued
	The registration statement for the Company’s IPO was declared effective on March 27, 2014. On April 2, 2014, the Company consummated the Public Offering of 4,600,000 shares of common stock (including 600,000 shares issued pursuant to the over-allotment option granted to the underwriter) at $6.00 per share and received from the underwriter net proceeds of $25,214,596 (net of underwriter’s discount of $2,208,000 and underwriter offering expenses of $177,404). The Company incurred additional offering expenses of $430,745, yielding net proceeds from the IPO of $24,783,851.	On November 8, 2012, the Company sold 1,924,813 shares of its common stock at a price of approximately $.0052 per share and representing aggregate proceeds of $10,000 to DvineWave Holdings LLC, an entity formed by the parents of Michael Leabman, the Company’s founder and prior to September 30, 2013, also its President and its Chief Technology Officer, to make an investment in the Company.
	IPO Underwriter Warrant	On January 28, 2013, Company sold 80,201 shares of its common stock to Michael Leabman at a price of approximately $.0052 per share for aggregate proceeds of $417.
	Simultaneous with the funding of the IPO, the Company issued to the underwriter a warrant to purchase 460,000 shares of common stock (“IPO Underwriter Warrant”) at an exercise price of $7.50 per share with an expiration date of April 2, 2024. The IPO underwriter warrant was recorded net of the proceeds from the IPO.	On March 4, 2013, the Company sold 668,337 shares of its common stock at a price of $0.24 per share to Absolute Ventures LLC, an affiliate of Mr. Greg Brewer, one of the Company’s directors for aggregate proceeds of $160,000.
	Sale of Common Stock	On May 7, 2013, the Company sold 20,050 shares of its common stock at a price of $0.24 per share to MS Investments, an affiliate of one of the company’s legal firms, Much Shelist, P.C. for aggregate proceeds of $4,800.
	The Company entered into a stock purchase agreement dated March 7, 2014, under which a strategic investor (“Strategic Investor”) agreed to purchase 210,527 shares of our common stock $0.0001 par value for gross proceeds of $1,000,000. On April 4, 2014, the Company issued 210,527 shares of common stock upon the receipt of the proceeds of $1,000,000 ($300,000 received on March 27, 2014, $700,000 received on April 4, 2014). In connection with this sale, the Company paid a commission of $100,000 to MDB. The shares issued are subject to a one year lock-up and a one year voting control agreement.

Stock_Based_Compensation

Stock Based Compensation	9 Months Ended															12 Months Ended
	Sep. 30, 2014															Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'															'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'															'
	Note 9 — Stock Based Compensation															Note 10 — Stock Based Compensation
																Adoption of 2013 Stock Plan
	Equity Incentive Plans															Effective as of May 9, 2013, the Board adopted the 2013 Stock Plan of DvineWave Inc. (the “2013 Stock Plan”). The 2013 Stock Plan was administered by the Board, and provided for the issuance of incentive and non-incentive stock options, stock purchase rights and restricted stock units, for the purchase of up to a total of 1,056,980 shares of the Company’s common stock to the Company’s employees and consultants (as determined by the Board). The Board, or a committee of the Board, had the authority to determine the amount, type and terms of each award. Pursuant to the 2013 Stock Plan, each option grant must have had an exercise price at or above the fair market value of the Company’s common stock on the date of grant in the case of a non-statutory stock option, or until the Company’s securities are listed on a recognized exchange, at 85% of fair value (as determined) under the 2013 Stock Plan of DvineWave Inc. (See Note 8 — Commitments and Contingencies).
																Adoption of Equity Incentive Plan
	2013 Equity Incentive Plan															In December 2013 the Company’s board and stockholders approved the “2013 Equity Incentive Plan”, providing for the issuance of equity based instruments aggregating an initial total of 1,042,167 shares which completely replaces the 2013 Stock Plan.
																Grant of Stock Option
	In December 2013 the Company’s board and stockholders approved the “2013 Equity Incentive Plan”, providing for the issuance of equity based instruments covering up to an initial total of 1,042,167 shares of common stock. Effective on March 27, 2014, the aggregate total shares which may be issued under the 2013 Equity Incentive Plan were increased to 2,335,967, as described below.															On December 12, 2013, Mr. Rizzone, the Company’s Chief Executive Officer, was granted an option under the 2013 Equity Incentive Plan to purchase 275,689 shares of the Company’s common stock, at a price of $1.68 per share, with a term of ten years and which vests  1/48 for each completed month of service and for purposes of vesting only, the first completed month of service was determined to be October 2013.
																The option has a grant date fair value of $258,373 utilizing the Black-Scholes option pricing model. The fair value of the employee stock option granted was estimated using the following assumptions:
	Effective on March 10, 2014, the Company’s board of directors and stockholders approved the First Amendment to the 2013 Equity Incentive Plan which provided for an increase in the aggregate number of shares of common stock that may be issued pursuant to the Plan to equal 18% of the total number of shares of common stock outstanding immediately following the completion of the IPO (assuming for this purpose the issuance of all shares issuable under the Company’s equity plans, the conversion into common stock of all outstanding securities that are convertible by their terms into common stock and the exercise of all options and warrants exercisable for shares of common stock and including shares and warrants issued to the underwriters for such IPO upon exercise of its over-allotment options).
	As of September 30, 2014, 428,987 shares of common stock remain eligible to be issued through equity based instruments under the 2013 Equity Incentive Plan.																12-Dec-13
																Price of Company’s stock	$	1.68
	2014 Non-Employee Equity Compensation Plan															Dividend yield		0.00%
																Expected volatility		60	%
	On March 6, 2014, the Company’s board of directors and stockholders approved the 2014 Non-Employee Equity Compensation Plan for the issuance of equity based instruments covering up to 250,000 shares of common stock to directors and other non-employees.															Risk-free interest rate		1.79	%
																Expected life		5.93 years
	As of September 30, 2014, 211,184 shares of common stock remains eligible to be issued through equity based instruments under the 2014 Non-Employee Equity Compensation Plan.															As of December 31, 2013 unamortized compensation expense related to unvested stock options was $240,225 which is expected to be recognized over a weighted average period of 3.7 years.
																Stock Option Award Activity
	Option Valuation															A summary of the status of the Company’s stock option plans and the changes during the years ended December 31, 2013 and 2012, is presented in the table below:
	The Company has computed the fair value of options granted using the Black-Scholes option pricing model. Option forfeitures are estimated at the time of valuation and reduce expense ratably over the vesting period. This estimate will be adjusted periodically based on the extent to which actual option forfeitures differ, or are expected to differ, from the previous estimate, when it is material. The expected term used for options issued to non-employees is the contractual life and the expected term used for options issued to employees is the estimated period of time that options granted are expected to be outstanding. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee option grants. Since the Company’s stock has not been publicly traded for a sufficiently long period of time, the Company is utilizing an expected volatility figure based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within its industry. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.
																	Number of			Weighted		Weighted		Weighted		Intrinsic
	Stock Options																Options			Average		Average		Average		Value
																				Exercise		Grant		Remaining
	On January 7, 2014, the Company’s board of directors granted to various employees and consultants from the 2013 Equity Incentive Plan, net of forfeitures through March 31, 2014, stock options to purchase an aggregate of 457,644 shares of the Company’s common stock at an exercise price of $2.49 per share and having a term of ten years. Included in these grants were 57,644 options to Michael Leabman, Chief Technical Officer, pursuant to his employment contract, 80,201 options to George Holmes, Vice President of Sales and Marketing, and 319,799 options to other employees and consultants. The option awards granted to Mr. Leabman vested 3/48ths on the date of grant, and will vest 1/48th monthly over the following 45 months. The option award granted to Mr. Holmes will cliff vest 25% of the award on October 1, 2014 and then will vest 1/48th of the initial award monthly for the following 36 months. Option awards granted to all other employees and consultants cliff vest 25% of the award on the later of the first anniversary of the date they started working for the Company or October 1, 2014 and then will vest 1/48th of the initial award monthly for the following 36 months. The options had an aggregate grant date fair value of $762,699 utilizing the Black-Scholes option pricing model.																			Price		Date Fair		Life In
																						Value		Years
	On February 27, 2014, the Company granted non-qualified stock options for the purchase of 25,979 shares of the Company’s common stock each to two new independent directors of the Company as part of their compensation for serving on the Company’s board of directors. The options have an exercise price of $3.63 per share and have a term of ten years. The Options vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014. The options had an aggregate grant date fair value of $100,000 utilizing the Black-Scholes option pricing model.															Outstanding October 30, 2012 (inception)		—
																Issued		—
	On March 15, 2014 and March 20, 2014, the Company granted non-qualified stock options from the 2014 Non-Employee Equity Compensation Plan for the purchase of an aggregate of 34,781 shares of the Company’s common stock to two new independent directors of the Company as part of their compensation for serving on the Company’s board of directors. The options have a weighted average exercise price of $5.45 per share and have a term of ten years. The Options vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014. The options had an aggregate grant date fair value of $100,000 utilizing the Black-Scholes option pricing model.															Exercised		—
																Forfeited		—
	On March 15, 2014, the Company’s board of directors granted to a single employee an option under the 2013 Equity Incentive Plan to purchase 80,201 shares of the Company’s common stock at an exercise price of $4.99.  The option award granted to the employee has a ten year term and cliff vests 25% of the award on the anniversary of the employee’s date of hire and then will vest 1/48th of the initial award monthly during the following 36 months. The option had a grant date fair value of $229,365 utilizing the Black-Scholes option pricing model.															Outstanding December 31, 2012		—
																Issued		275,689		$	1.68	$	0.23
	On March 26, 2014, the Company’s board of directors granted to Mr. Rizzone, the Company’s Chief Executive Officer, an option under the 2013 Equity Incentive Plan to purchase 496,546 shares of the Company’s common stock, at a price of $6.00 per share, with a term of ten years and which vests 6/48 of the award on the grant date and 1/48 of the award on the last day of each of the subsequent 42 months. The option had a grant date fair value of $1,667,784 utilizing the Black-Scholes option pricing model.															Exercised		—
																Forfeited		—
	On March 26, 2014, the Company’s board of directors granted to Michael Leabman, Chief Technical Officer, pursuant to his employment contract a stock option under the 2013 Equity Incentive Plan to purchase 251,474 shares of the Company’s common stock at an exercise price of $6.00.  The option award granted to Mr. Leabman has a ten year term and vests 6/48th of the award on the grant date and 1/48th of the award on the last day of each of the subsequent 42 months. The option had a grant date fair value of $844,643 utilizing the Black-Scholes option pricing model.															Outstanding December 31, 2013		275,689		$	1.68	$	0.23		9.9 years	$	—
																Exercisable at December 31, 2013		17,231		$	1.68	$	0.23		9.9 years	$	—
	On March 26, 2014, the Company’s board of directors granted to Mr. Holmes a stock option under the 2013 Equity Incentive Plan to purchase 89,672 shares of the Company’s common stock at an exercise price of $6.00.  The option award granted to the consultant has a ten year term and vests 25% of the award on September 30, 2014 and 1/48th of the award on the last day of each of the subsequent 36 months. The option had a grant date fair value of $303,869 utilizing the Black-Scholes option pricing model.
	The Company estimated the fair value of stock options awarded during the nine months ended September 30, 2014 using the Black-Scholes option pricing model. The fair values of stock options granted were estimated using the following assumptions:
			Option Grants
			Awarded During the
			Nine Months Ended
			September 30, 2014
	Stock Price			$2.49 to $6.00
	Dividend Yield			0	%
	Expected Volatility			60	%
	Risk-free interest rate			1.30% to 2.03%
	Expected Life			3.75 to 6.25 years
	As of September 30, 2014, the unamortized value of options held by employees was $2,937,130. As of September 30, 2014, the unamortized portion will be expensed over a weighted average period of 2.96 years.
	Stock Option Award Activity
	The following is a summary of the Company’s stock option activity during the nine months ended September 30, 2014:
			Number of			Weighted			Weighted			Weighted		Intrinsic
			Options			Average			Average			Average		Value
						Exercise			Grant Date			Remaining
						Price			Fair Value			Life In
												Years
	Outstanding, January 1, 2014			275,689		$	1.68		$	—			—	$	—
	Granted			1,542,477			4.63			2.6			—		—
	Exercised			—			—			—			—		—
	Forfeited			-166,981			2.52			1.44			—		—
	Outstanding September 30, 2014			1,651,185		$	4.35		$	2.45			9.4	$	11,538,844
	Exercisable, January 1, 2014			17,231		$	1.68		$	—			—	$	—
	Vested			340,580			4.88			—			—		—
	Exercised			—			—			—			—		—
	Forfeited			—			—			—			—		—
	Exercisable, September 30, 2014			357,811		$	4.73		$	2.62			9.4	$	2,365,792
The following table presents information related to stock options outstanding and exercisable at September 30, 2014:
Options Outstanding					Options Exercisable
Exercise Price		Outstanding			Weighted Average			Exercisable Number of
		Number of			Remaining Life In			Options
		Options			Years
$	1.68			275,689			9.2			68,922
	2.49			370,864			9.3			14,411
	3.63			51,958			9.4			38,969
	4.99			99,214			9.5			14,260
	6			853,460			9.5			221,249
				1,651,185			9.4			357,811
Restricted Stock Units (“RSUs”)
On June 3, 2014, the compensation committee of the board of directors of the Company granted to a member of the Company’s advisory board, an RSU award under which the holder has the right to receive 4,035 shares of common stock. The award was granted under the 2014 Non-Employee Equity Compensation Plan. The RSU had a grant date fair value of $49,590 based upon the fair value of the Company’s common stock on the date of grant. This RSU had 1,009 shares vested as of September 30, 2014 and vests 504 shares on each of the next six succeeding three month anniversaries of the grant date.
On July 14, 2014, the compensation committee of the board of directors granted to George Holmes an RSU under which the holder has the right to receive 44,836 shares of the Company’s common stock. The award was granted under the 2013 Equity Incentive Plan. The RSU had a grant date fair value of $593,180 based upon the fair value of the Company’s common stock on the date of grant. The award granted to Mr. Holmes vests over four years through March 28, 2018. Pursuant to the terms of the award, the shares not vested terminate upon separation from the Company.
On July 14, 2014, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive 228,500 shares of the Company’s common stock. These awards were granted under the 2013 Equity Incentive Plan and the RSU’s had an aggregate grant date fair value of $3,023,055 based upon the fair value of the Company’s common stock on the date of grant. The awards granted vest over four years through March 28, 2018. Pursuant to the terms of the awards, the shares not vested terminate upon separation from the Company.
On August 14, 2014, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive 86,823 shares of the Company’s common stock. These awards were granted under the 2013 Equity Incentive Plan and the RSU’s had an aggregate grant date fair value of $981,100 based upon the fair value of the Company’s common stock on the date of grant. The awards granted vest over four years beginning on the first anniversary of the employee’s date of hire. Pursuant to the terms of the awards, the shares not vested terminate upon separation from the Company.
In addition, on August 14, 2014, the compensation committee of the board of directors granted two inducement RSU awards to Cesar Johnston, the Company’s Senior Vice President of Engineering. Under the first award, Mr. Johnston has the right to receive 100,000 shares of the Company’s common stock and this award vests over four years beginning on the first anniversary of the date of grant. In addition, Mr. Johnston was granted 20,000 performance based RSU awards. The RSU’s had an aggregate grant date fair value of $1,356,000 based upon the fair value of the Company’s common stock on the date of grant. Pursuant to the terms of the awards, the shares not vested terminate upon separation from the Company.
The Company accounts for RSUs granted to consultants using the accounting guidance included in ASC 505-50 “Equity-Based Payments to Non-Employees” (“ASC 505-50”). In accordance with ASC 505-50, the Company estimates the fair value of the unvested portion of the RSU award each reporting period using the closing price of the Company’s common stock.
At September 30, 2014, the unamortized value of the RSU was $5,328,318. The unamortized amount will be expensed over a weighted period of 3.51 years.
A summary of the activity related to RSUs for the nine months ended September 30, 2014 is presented below:
		Total			Weighted			Total Grant
					Average			Date Fair
					Grant			Value
					Date Fair
					Value
Nonvested at January 1, 2014			—		$	—		$	—
RSUs granted			484,194			12.4			6,002,925
RSUs vested			-4,509			11.52			-51,948
RSUs forfeited			-17,625			13.23			-233,178
Nonvested at September 30, 2014			462,060		$	12.37			5,717,799
Stock-Based Compensation Expense
The following tables summarize total stock based compensation costs recognized for the three and nine months ended September 30, 2014 and 2013:
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
Stock options		$	325,634		$	—		$	1,070,939		$	—
RSUs			381,856			—			389,482			—
IR warrant			39,410			—			198,983			—
Total		$	746,900		$	—		$	1,659,404		$	—
The total amount of stock-based compensation was reflected within the condensed statements of operations as:
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
Research and development		$	329,138		$	—		$	568,390		$	—
General and administrative			165,228			—			657,738			—
Marketing			252,534			—			433,276			—
Total		$	746,900		$	—		$	1,659,404		$	—

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	Note 11 — Income Taxes
	For the year ended December 31, 2013 and for the period October 30, 2012 (inception) through December 31, 2012, we incurred losses of $5,521,081 and $21,287, respectively.
	Significant components of the Company’s net deferred tax assets at December 31, 2013 and 2012 are as follows:
		December 31,
	Deferred tax assets:	2013			2012
	Net operating loss carryforwards	$	900,830		$	—
	Research and development costs		845,900			6,807
	Start-up and organizational costs		1,554			1,665
	Stock-based compensation		647			—
	Other accruals		90,680			—
	Total gross deferred tax assets		1,839,611			8,472
	Less: valuation allowance		-1,839,611			-8,472
	Deferred tax assets, net	$	—		$	—
	As of December 31, 2013, the Company had approximately $2,263,391 of federal and state net operating losses (“NOL”), available for income tax purposes that may be carried forward to offset future taxable income, if any. The federal carryforwards expire in the year 2033.
	If not used, these NOL’s may be subject to limitation under Section 382 of the Internal Revenue Code (“IRC”) should there be a greater than 50% ownership change as determined under the regulations. The Company’s net deferred tax assets are subject to a 100% valuation allowance because it is currently more likely than not that the benefit of the net deferred tax asset will not be realized in future periods. The valuation allowances related to the Company’s net deferred tax assets increased by approximately $1,831,139 and $8,472 for the periods ended December 31, 2013 and 2012, respectively.
	A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:
		For the Year			For the period
		Ended			October 30, 2012
		December 31,			(Inception)
		2013			through December
					31, 2012
	Tax benefit at federal statutory rate		-34	%		-34	%
	State income taxes		-5.8			-5.8
	Permanent difference:
	Stock based compensation		0.1			—
	Derivative instrument issuance - financing warrant		1.3			—
	General and administrative expense - consulting warrant		3.9			—
	Change in fair value of derivative liability		1.3			—
	Increase in valuation allowance		33.2			39.8
	Effective income tax rate		0	%		0	%

Subsequent_Events

Subsequent Events	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Subsequent Events [Abstract]	'	'
Subsequent Events [Text Block]	'	'
	Note 10 — Subsequent Events	Note 12 — Subsequent Events
	Grant of RSUs	Employee Option Grants
	On November 13, 2014, the compensation committee of the board of directors granted various employees and consultants inducement RSU awards, under which the holders have the right to receive an aggregate of 261,686 shares of the Company’s common stock. These awards vest in four equal annual installments. Pursuant to the terms of the awards, the shares not vested are forfeited upon separation from the Company.	On January 7, 2014, the Company’s board of directors granted, net of forfeitures through March 20, 2014, to various employees and consultants, stock options to purchase an aggregate of 457,644 shares of our common stock at an exercise price of $2.49 per share. Included in the grant was an option to purchase 57,644 shares of common stock to Michael Leabman, Chief Technical Officer pursuant to his employment contract and an option to purchase 80,201 shares of common stock to Thomas Iwanski, Interim Chief Financial Officer, 80,201 shares of common stock to George Holmes, Vice President of Sales and Marketing and 319,799 to other employees of the Company. These stock option grants were issued from the 2013 Stock Plan. The option awards granted to Mr. Leabman vested  3/48ths on the date of grant, and will vest  1/48th monthly over the following 45 months. The option award granted to Mr. Iwanski and Mr. Holmes will cliff vest 25% of the award on October 1, 2014 and then will vest  1/48th of the initial award monthly for the following 36 months. Option awards granted to all other employees and consultants cliff vest 25% of the award on the later of the first anniversary of the date they started working for the Company or October 1, 2014 and then will vest  1/48th of the initial award monthly for the following 36 months.
	On November 13, 2014, the compensation committee of the board of directors granted to a former employee and a consultant, RSUs under which the holders have the right to receive an aggregate of 3,836 shares of the Company’s common stock. These awards were granted under the 2013 Equity Incentive Plan and were fully vested at the time of grant.	On March 15, 2014, the Company’s board of directors granted to a single employee a stock option to purchase 80,201 shares of the Company’s common stock at an exercise price of $4.99. The option award granted to the employee cliff vests 25% of the award on the anniversary of the employee’s start date and then will vest  1/48th of the initial award monthly during the following 36 months.
	On November 13, 2014, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive an aggregate of 5,100 shares of the Company’s common stock in connection with the filing of certain patent applications. These awards were granted under the 2013 Equity Incentive Plan and vest on various dates over the twelve month period beginning on the date of grant.	Investor Relations Agreement
	Stock Issuance	Effective January 13, 2014, the Company entered into an agreement with a vendor (“IR Firm”) to provide investor relations services to the Company. Pursuant to the agreement, in addition to monthly cash compensation of $8,000 per month, upon the consummation of the IPO the Company will issue a consulting warrant (“IR Consulting Warrant”) for the purchase of 36,000 shares of common stock. The IR Consulting Warrant will have a strike price equivalent to 130% of the IPO price. The IR Consulting Warrant will have an initial catch up vesting equivalent to 3,000 shares per month of service, partial months to be prorated on a thirty (30) day basis, from the effective date of this agreement until the date the IPO is effective. Thereafter, the IR Consulting Warrant will vest at a rate of 3,000 shares per month of service. In addition, the Company will issue to the IR Firm incentive warrants (“IR Incentive Warrants”) to purchase 5,000 shares of common stock with a strike price equal to the IPO price plus 30% for each qualified investor, institutional or brokerage firm that purchases at least $250,000 in value of the Company’s common shares at the IPO price or greater in the open market on or after the 46th day following completion of the IPO. All IR Incentive Warrants granted during a six month period will collectively vest at each six-month anniversary. Shares underlining both the IR Consulting Warrant and the IR Incentive Warrants will be subject to any Company lock-up period consistent with other stockholders. Both the IR Consulting Warrant and IR Incentive Warrants will have an expiration date four (4) years from the grant date. The shares underlying both the IR Consulting Warrant and the IR Incentive Warrants will either be registered at the next available opportunity or the warrants will include a cashless exercise provision.
	On November 13, 2014, the Company issued 5,353 shares of restricted common stock to a consultant for services rendered.	2014 Non-Employee Equity Compensation Plan
		On March 6, 2014, after the Company received waivers and consents from MDB and greater than 50% of the holders of the Convertible Notes, the Company’s board of directors and stockholders approved the 2014 Non-Employee Equity Compensation Plan for the issuance of 249,875 shares of common stock to directors and other non-employees.
		Amendment to 2013 Equity Incentive Plan
		On March 6, 2014, after the Company received waivers and consents from MDB and greater than 50% of the holders of the Convertible Notes, the Company’s board of directors and stockholders approved the First Amendment to the 2013 Equity Incentive Plan which provided for an increase in the aggregate number of shares of common stock that may be issued pursuant to the Plan to equal 18% of the total number of shares of common stock outstanding immediately following the completion of the IPO (assuming for this purpose) the issuance of all shares issuable under the Company’s equity plans, the conversion into common stock of all outstanding securities that are convertible by their terms into common stock and the exercise of all options and warrants exercisable for shares of common stock and including shares and warrants issued to the underwriters for such IPO upon exercise of its over-allotment options.
		Director Option Grants
		On February 27, 2014, the Company granted non-qualified stock options for the purchase of 25,979 shares of the Company’s common stock each to two new independent directors of the Company as part of their compensation for serving on the Company’s board of directors. The options have an exercise price of $3.63 per share and have a term of ten years. The Options vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014. Unless otherwise modified, the grantees have one-year after separation of service to exercise any vested options. The shares underlining these options are subject to a one year lock-up beginning with the effective date of the IPO.
		On March 15, 2014 and March 20, 2014, the Company granted non-qualified stock options from the 2014 Non-Employee Equity Compensation Plan for the purchase of an aggregate of 34,781 shares of the Company’s common stock to two new independent directors of the Company as part of their compensation for serving on the Company’s board of directors. The options have a weighted average exercise price of $5.47 per share and have a term of ten years. The Options vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014. Unless otherwise modified, the grantees have one year after separation of service to exercise any vested options. The shares underlying these options are subject to a one year lock up beginning with the effective date of the IPO.
		Company Name Change
		On January 2, 2014, the board of directors and stockholders approved the name change for the Company to Energous Corporation from DvineWave Inc.
		Sale of Common Stock
		The Company entered into a stock purchase agreement dated March 7, 2014, under which a strategic investor has agreed to purchase 210,526 shares of our common stock $0.0001 par value for gross proceeds of $1,000,000. In connection with this sale, the Company will pay a commission of $100,000 to MDB. The shares to be issued are subject to the one year lock-up and a one year voting control agreement.
		Amendment to Certificate of Incorporation
		On February 25, 2014, the Company’s board of directors and stockholders approved the Second Amended and Restated Certificate of Incorporation which increased the authorized shares to 60,000,000 of which 10,000,000 shares are designated as preferred stock. In addition, a special meeting of stockholders can only be called by the Chairman, Chief Executive Officer, President or the majority of the board of directors and shall be limited to matters relating to the purpose or purposes stated in the notice of meeting. Any actions required, as a result of a special stockholder meeting, can only be taken upon the vote of the stockholders and not by written consent. The stockholders empowered the board of directors at any time prior to the effectiveness of the filing of this Second Amendment and Restated Certificate to abandon the proposed amendment.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)

9 Months Ended

12 Months Ended

Sep. 30, 2014

Dec. 31, 2013

Accounting Policies [Abstract]

'

'

Basis of Accounting, Policy [Policy Text Block]

'

'

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. These condensed financial statements should be read in conjunction with the financial statements for the year ended December 31, 2013 and related notes thereto included elsewhere in the prospectus of which these financial statements are a part.

The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).

Reclassification, Policy [Policy Text Block]

'

'

Reclassification

Certain amounts within the fiscal year 2013 consolidated financial statements have been reclassified in order to conform to the fiscal year 2014 presentation. These reclassification had no impact on previously reported results of operations or stockholder’s equity.

Use of Estimates, Policy [Policy Text Block]

'

'

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the condensed financial statements as well as the reported expenses during the reporting periods.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements as well as the reported expenses during the reporting periods.

The Company’s significant estimates and assumptions include the valuation of the Company’s common stock, the valuation of stock-based compensation instruments and the valuation of derivative financial instruments, the amortization of deferred financing costs and the useful lives of long-lived assets, and income tax expense. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates.

The Company’s significant estimates and assumptions include the valuation of the Company’s common stock and the valuation of derivative financial instruments, the amortization of deferred financing costs, the amortization and recoverability of capitalized patent costs and useful lives of long-lived assets, and income tax expense, some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates.

Cash and Cash Equivalents, Policy [Policy Text Block]

'

'

Cash and Cash Equivalents

The Company maintains cash in bank accounts, consisting solely of deposits held at major banks, which, at times, may exceed federally insured limits. Cash equivalents include investments in open ended money market accounts held at the same major banks. The Company has not experienced any losses in such accounts and periodically evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.

Property, Plant and Equipment, Policy [Policy Text Block]

'

'

Property and Equipment

Property and equipment are stated at cost net of accumulated depreciation, which is recorded using the straight line method at rates sufficient to charge the cost of depreciable assets to operations over their estimated useful lives, which range from 3 to 7 years. Maintenance and repairs are charged to operations as incurred.

Deferred Charges, Policy [Policy Text Block]

'

'

Deferred Offering Costs

Deferred offering costs consist principally of legal, accounting and other fees incurred through the balance sheet date that are directly related to the Company’s IPO and that will be charged to stockholders’ equity upon the receipt of the capital raised.

Intangible Assets, Finite-Lived, Policy [Policy Text Block]

'

'

Trademarks

Legal and filing fees incurred in connection with the registration of trademarks are capitalized.

Research and Development Expense, Policy [Policy Text Block]

'

'

Research and Development

Research and Development

Research and development expenses are charged to operations as incurred. For internally developed patents, all costs incurred to the point when a patent application is to be filed are expensed as incurred as research and development expense. Patent application costs, generally legal costs, are expensed as research and development costs until such time as the future economic benefits of such patents become more certain. The Company incurred research and development costs of $3,699,057 and $583,524 for the three months ended September 30, 2014 and 2013, respectively, and $6,184,762 and $1,019,950 for the nine months ended September 30, 2014 and 2013, respectively.

Research and development expenses are charged to operations as incurred. For internally developed patents, all costs incurred to the point when a patent application is to be filed are expended as incurred as research and development expense. Patent application costs, generally legal costs, are expensed as research and development costs until such time as the future economic benefits of such patents become more certain. The Company incurred research and development costs of $2,109,890, $17,103 and $2,126,993 for the year ended December 31, 2013, for the period October 30, 2012 (inception) through December 31, 2012 and during the period from October 31, 2012 (inception) through December 31, 2013, respectively.

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

'

'

Impairment of Long-lived Assets

The Company reviews for the impairment of long-lived assets, including trademarks, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Included in general and administrative expenses for the write off of an abandoned trademark is $4,725, $0 and $4,725 for the year ended December 31, 2013, for the period October 30, 2012 (inception) through December 31, 2012 and during the period from October 31, 2012 (inception) through December 31, 2013, respectively.

Income Tax, Policy [Policy Text Block]

'

'

Income Taxes

Income Taxes

Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of September 30, 2014, no liability for unrecognized tax benefits was required to be reported. The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during the three and nine months ended September 30, 2014 and 2013.

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse.

For the year ended December 31, 2013 and for the period October 30, 2012 (inception) through December 31, 2012, the Company had approximately $2,108,000 and $17,000, respectively, of research and development expenses capitalized for federal income tax purposes, with amortization commencing upon the Company receiving an economic benefit from the related research. For the period October 30, 2012 (inception) through December 31, 2012, $4,000 of organization costs were capitalized and will be amortized for federal income tax purposes over 15 years. Accordingly, as of December 31, 2013, the Company had approximately $2,263,391 gross federal and state net operating loss carryovers (“NOLs”). For the year ended December 31, 2013 and for the period October 30, 2012 (inception) through December 31, 2012, the deferred tax assets in connection with the net operating loss carryover, the research and development costs and the organizational costs were fully reserved, and the Company’s effective tax rate was 0%.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the future generation of taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. Based on this assessment, management has established a full valuation allowance against all of the net deferred tax assets for each period, since it is more likely than not that all of the deferred tax assets will not be realized.

Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of December 31, 2013, no liability for unrecognized tax benefits was required to be reported. The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded for the year ended December 31, 2013 or for the period October 30, 2012 (inception) through December 31, 2012.

Earnings Per Share, Policy [Policy Text Block]

'

'

Net Income (Loss) Per Common Share

Net Loss Per Common Share

Basic net income (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method), the vesting of restricted stock units (“RSUs”), the exercise and/or conversion of the Company’s convertible notes (using the if-converted method). The computation of diluted loss per share excludes potentially dilutive securities of 3,060,301 and 3,210,126 for the three months ended September 30, 2014 and 2013, respectively, and 3,060,301 and 3,210,126 for the nine months ended September 30, 2014 and 2013, respectively, because their inclusion would be antidilutive.

Basic net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share are computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of the conversion of the Company’s convertible notes and warrants (using the if-converted method). The computation of basic loss per share for the year ended December 31, 2013 and for the period October 30, 2012 (inception) through December 31, 2012 excludes potentially dilutive securities of 3,525,907 and 0, respectively, because their inclusion would be antidilutive. As a result, the computations of net loss per share for each period presented is the same for both basic and fully diluted.

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share, because the effect of their inclusion would have been anti-dilutive.

For the Three Months Ended

For the Nine Months Ended

For the Year

For the Period

September 30,

September 30,

Ended

October 30,

2014

2013

2014

2013

December 31,

2012 (Inception)

Convertible Notes – principal

—

2,650,858

—

2,650,858

2013

Through

Convertible Notes – accrued interest

—

60,135

—

60,135

December 31,

Consulting Warrant to purchase common stock

278,228

278,228

278,228

278,228

2012

Financing Warrant to purchase common stock

152,778

220,905

152,778

220,905

Convertible Notes – principal

2,650,858

—

IPO Warrants to purchase common stock

460,000

—

460,000

—

Convertible Notes – accrued interest

100,227

—

IR Consulting Warrant

36,000

—

36,000

—

Consulting Warrant to purchase common stock

278,228

—

Options to purchase common stock

1,671,235

—

1,671,235

—

Financing Warrant to purchase common stock

220,905

—

RSUs

462,060

—

462,060

—

Options to purchase common stock

275,689

—

Total potentially dilutive securities

3,060,301

3,210,126

3,060,301

3,210,126

Total potentially dilutive securities

3,525,907

—

Fair Value Measurement, Policy [Policy Text Block]

'

'

Fair Value Measurements

Fair Value Measurements

The carrying amounts of cash and cash equivalents, accounts payable and accrued expenses, approximate fair value due to the short-term nature of these instruments. Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:

The carrying amounts of cash and cash equivalents, accounts payable and accrued expenses, approximate fair value due to the short-term nature of these instruments.

Level 1

Quoted prices in active markets for identical assets or liabilities.

Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:

Level 2

Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.

Level 1

Quoted prices in active markets for identical assets or liabilities.

Level 3

Significant unobservable inputs that cannot be corroborated by market data.

Level 2

Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.

The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of the liabilities that are measured at fair value on a recurring basis.

Level 3

Significant unobservable inputs that cannot be corroborated by market data.

The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of the assets that are measured at fair value on a recurring basis:

Total

Quoted Prices

Quoted Prices

Significant

in Active

for Similar

Unobservable

Total

Quoted Prices in

Quoted Prices

Significant

Markets for

Assets or

Inputs

Active Markets

for Similar

Unobservable

Identical

Liabilities in

(Level 3)

for Identical

Assets or

Inputs

Assets or

Active

Assets or

Liabilities in

(Level 3)

Liabilities

Markets

Liabilities

Active Markets

(Level 1)

(Level 2)

(Level 1)

(Level 2)

Derivative Liabilities:

Derivative Liabilities:

December 31, 2013:

31-Dec-12

$

—

$

—

$

—

$

—

Conversion Feature

$

5,573,000

$

—

$

—

$

5,573,000

December 31, 2013:

Financing Warrant

175,000

—

—

175,000

Conversion Feature

$

5,573,000

$

—

$

—

$

5,573,000

Consulting Warrant

529,000

—

—

529,000

Financing Warrant

175,000

—

—

175,000

Total

$

6,277,000

$

—

$

—

$

6,277,000

Consulting Warrant

529,000

—

—

529,000

As of September 30, 2014, the Company no longer had financial instruments which were derivative liabilities.

Total

$

6,277,000

$

—

$

—

$

6,277,000

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:

For the

For the Year

For the Period

Nine Months

Ended

October 30,

Ended

December 31,

2012 (inception)

September 30,

2013

Through

2014

December 31,

Beginning balance

$

6,277,000

2012

Change in fair value of conversion feature and warrants

26,265,177

Beginning balance

$

—

$

—

Extinguishment of derivative liability upon conversion of Convertible Notes

(26,790,177

)

Aggregate fair value of conversion feature and warrants upon issuance

6,100,000

—

Extinguishment of derivative liability upon modification of Financing Warrant

(1,733,000

)

Change in fair value of conversion feature and warrants

177,000

—

Extinguishment of derivative liability upon modification of Consulting Warrant

(4,019,000

)

Ending balance

$

6,277,000

$

—

Ending balance

$

—

The conversion feature of the Convertible Notes was measured at fair value using a Monte Carlo simulation and is classified within Level 3 of the valuation hierarchy. The warrant liabilities for the Financing Warrant and the Consulting Warrant were measured at fair value using a Monte Carlo simulation and are classified within Level 3 of the valuation hierarchy. The significant assumptions and valuation methods that the Company used to determine fair value and the change in fair value of the Company’s derivative financial instruments are discussed in Note 7 — Private Placement.

The conversion feature of the Convertible Notes immediately prior to conversion was measured at fair value using a Monte Carlo simulation (which also represented the intrinsic value of the conversion feature) and was classified within Level 3 of the valuation hierarchy. The warrant liabilities for the Financing Warrant and the Consulting Warrant, immediately prior to modification were measured at fair value using a Monte Carlo simulation and were classified within Level 3 of the valuation hierarchy. The significant assumptions and valuation methods that the Company used to determine fair value and the change in fair value of the Company’s derivative financial instruments are discussed in Note 6 — Private Placement.

Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivate liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Chief Financial Officer determined its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Chief Financial Officer with support from the Company’s consultants and which are approved by the Chief Financial Officer.

Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Interim Chief Financial Officer determined its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Interim Chief Financial Officer with support from the Company’s consultants and which are approved by the Interim Chief Financial Officer.

Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.

Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.

The Company uses a Monte Carlo model to value Level 3 financial liabilities at inception and on subsequent valuation dates. This simulation incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as, volatility. The Company also used a binomial simulation and Black-Scholes economic model as supplemental valuation tools in order to validate the reasonableness of the results of the Monte Carlo simulation when measuring the Financing Warrant and the Consulting Warrant.

The Company used a Monte Carlo model to value Level 3 financial liabilities at inception and on subsequent valuation dates, except that the conversion feature of the convertible notes immediately prior to conversion was valued at intrinsic value. This simulation incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as, volatility. The Company also used a binomial simulation and Black-Scholes economic model as supplemental valuation tools in order to validate the reasonableness of the results of the Monte Carlo simulation when measuring the Financing Warrant and the Consulting Warrant.

A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation, would result in a significantly lower fair value measurement. Changes in the values of the derivative liabilities are recorded in Change in Fair Value of Derivative Liabilities within Other Expense (Income) on the Company’s Statements of Operations.

A significant increase in the volatility or a significant increase in the Company’s stock price, in isolation, would result in a significantly higher fair value measurement. Changes in the values of the derivative liabilities were recorded in Change in Fair Value of Derivative Liabilities within Other Expense (Income) on the Company’s Statements of Operations.

As of December 31, 2013 and 2012, there were no transfers in or out of level 3 from other levels in the fair value hierarchy.

As of September 30, 2014, there were no transfers in or out of level 3 from other levels in the fair value hierarchy.

In accordance with the provisions of ASC 815, the Company presented the conversion feature and warrant liabilities at fair value on its balance sheet, with the corresponding changes in fair value recorded in the Company’s statement of operations for the applicable reporting periods.

In accordance with the provisions of ASC 815, the Company presented the conversion feature and warrant liabilities at fair value on its balance sheet, with the corresponding changes in fair value recorded in the Company’s statement of operations for the applicable reporting periods.

The fair value of the Company’s common stock was determined by a third party valuation consultant, and was derived from the valuation of the Company using a methodology which back-solved to the fair value of the common stock on May 16, 2013 and December 31, 2013, based upon the Company’s capitalization, existing dilutive securities and the proceeds received from the issuance of the Convertible Notes. For the purposes of this back-solve computation, management assumed that the Convertible Notes would convert at $2.07 per share (the floor level), and that the Financing Warrant would have an exercise price of $2.49 per common share or, 120% of the exercise price of the Convertible Notes.

Management determined that the results of its valuations are reasonable.

Management determined that the results of its valuations are reasonable.

Convertible Instruments Policy [Policy Text Block]

'

'

Convertible Instruments

The Company accounts for hybrid contracts that feature conversion options in accordance with ASC 815 “Derivatives and Hedging Activities,” (“ASC 815”) and ASC 480 “Distinguishing Liabilities from Equity” (“ASC 480”), which require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria includes circumstances in which (i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments which have been determined to be free standing derivative financial instruments (when the Company has determined that the embedded conversion options should be bifurcated from their host instruments) in accordance with ASC 815. Under ASC 815, a portion of the proceeds received upon the issuance of the hybrid contract are allocated to the fair value of the derivative. The derivative is subsequently marked to market at each reporting date based on current fair value, with the changes in fair value reported in results of operations.

Conversion options that contain variable settlement features such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract generally result in their bifurcation from the host instrument.

The Company accounts for convertible debt instruments, when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, in accordance with ASC 470-20 “Debt with Conversion and Other Options”. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt.

Derivatives, Policy [Policy Text Block]

'

'

Common Stock Purchase Warrants and Other Derivative Financial Instruments

The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provides a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company’s own stock as defined in ASC 815-40 “Contracts in Entity’s Own Equity” (“ASC 815-40”). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of common stock purchase warrants and other free standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities or equity is required.

New Accounting Pronouncements, Policy [Policy Text Block]

'

'

Recent Accounting Pronouncements

In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation.” This ASU removes the definition of a development stage entity from the ASC, thereby removing the financial reporting distinction between development stage entities and other reporting entities from GAAP. In addition, the ASU eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and stockholders’ equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. This ASU is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. Early adoption is permitted. The Company has elected to adopt this ASU effective with the Quarterly Report on Form 10-Q filed on August 14, 2014 and its adoption resulted in the removal of previously required development stage disclosures.

The FASB has issued ASU No. 2014-12, Compensation — Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company has elected to adopt this ASU effective with this Quarterly Report and its adoption is not expected to have a material effect.

In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which supersedes the revenue recognition requirements in ASC Topic 605, “Revenue Recognition,” and most industry-specific guidance. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The amendments in the ASU must be applied using one of two retrospective methods and are effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The Company will evaluate the effects, if any, that adoption of this guidance will have on its financial statements.

Subsequent Events, Policy [Policy Text Block]

'

'

Management’s Evaluation of Subsequent Events

Management’s Evaluation of Subsequent Events

The Company evaluates events that have occurred after the balance sheet date of September 30, 2014, through the date which the condensed financial statements are issued. Based upon the review, other than described in Note 10 — Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed financial statements.

The Company evaluates events that have occurred after the balance sheet date of December 31, 2013, through the date which the financial statements were available to be issued. Based upon the review, other than described in Note 12 — Subsequent Event, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended										12 Months Ended
	Sep. 30, 2014										Dec. 31, 2013
Accounting Policies [Abstract]	'										'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'										'
	Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.										Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share, because the effect of their inclusion would have been anti-dilutive.
		For the Three Months Ended					For the Nine Months Ended					For the Year		For the Period
		September 30,					September 30,					Ended		October 30,
		2014			2013		2014		2013			December 31,		2012 (Inception)
	Convertible Notes – principal		—			2,650,858		—		2,650,858		2013		Through
	Convertible Notes – accrued interest		—			60,135		—		60,135				December 31,
	Consulting Warrant to purchase common stock		278,228			278,228		278,228		278,228				2012
	Financing Warrant to purchase common stock		152,778			220,905		152,778		220,905	Convertible Notes – principal		2,650,858		—
	IPO Warrants to purchase common stock		460,000			—		460,000		—	Convertible Notes – accrued interest		100,227		—
	IR Consulting Warrant		36,000			—		36,000		—	Consulting Warrant to purchase common stock		278,228		—
	Options to purchase common stock		1,671,235			—		1,671,235		—	Financing Warrant to purchase common stock		220,905		—
	RSUs		462,060			—		462,060		—	Options to purchase common stock		275,689		—
	Total potentially dilutive securities		3,060,301			3,210,126		3,060,301		3,210,126	Total potentially dilutive securities		3,525,907		—
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'										'
	The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of the liabilities that are measured at fair value on a recurring basis.										The following table provides a summary of the assets that are measured at fair value on a recurring basis:
		Total			Quoted Prices		Quoted Prices		Significant			Total		Quoted Prices in		Quoted Prices		Significant
					in Active		for Similar		Unobservable					Active Markets		for Similar		Unobservable
					Markets for		Assets or		Inputs					for Identical		Assets or		Inputs
					Identical		Liabilities in		(Level 3)					Assets or		Liabilities in		(Level 3)
					Assets or		Active							Liabilities		Active Markets
					Liabilities		Markets							(Level 1)		(Level 2)
					(Level 1)		(Level 2)				Derivative Liabilities:
	Derivative Liabilities:										31-Dec-12	$	—	$	—	$	—	$	—
	December 31, 2013:										December 31, 2013:
	Conversion Feature	$	5,573,000		$	—	$	—	$	5,573,000	Conversion Feature	$	5,573,000	$	—	$	—	$	5,573,000
	Financing Warrant		175,000			—		—		175,000	Financing Warrant		175,000		—		—		175,000
	Consulting Warrant		529,000			—		—		529,000	Consulting Warrant		529,000		—		—		529,000
	Total	$	6,277,000		$	—	$	—	$	6,277,000	Total	$	6,277,000	$	—	$	—	$	6,277,000
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'										'
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:										The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:
		For the										For the Year		For the Period
		Nine Months										Ended		October 30,
		Ended										December 31,		2012 (inception)
		September 30,										2013		Through
		2014												December 31,
	Beginning balance	$	6,277,000											2012
	Change in fair value of conversion feature and warrants		26,265,177								Beginning balance	$	—	$	—
	Extinguishment of derivative liability upon conversion of Convertible Notes		(26,790,177	)							Aggregate fair value of conversion feature and warrants upon issuance		6,100,000		—
	Extinguishment of derivative liability upon modification of Financing Warrant		(1,733,000	)							Change in fair value of conversion feature and warrants		177,000		—
	Extinguishment of derivative liability upon modification of Consulting Warrant		(4,019,000	)							Ending balance	$	6,277,000	$	—
	Ending balance	$	—

Property_and_Equipment_Tables

Property and Equipment (Tables)	9 Months Ended							12 Months Ended
	Sep. 30, 2014							Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'							'
Property, Plant and Equipment [Table Text Block]	'							'
	Property and equipment are as follows:							Property and equipment are as follows:
		As of							As of December 31,
		September 30,			December 31,				2013			2012
		2014			2013			Computer software	$	114,876			—
	Computer software	$	369,453		$	114,876		Computer hardware		28,779			—
	Computer hardware		492,852			36,240		Furniture and fixtures		35,919			—
	Furniture and fixtures		277,679			28,458		Leasehold improvements		14,755			—
	Leasehold improvements		341,104			14,755				194,329			—
			1,481,088			194,329		Less – Accumulated depreciation		(4,717	)		—
	Less – Accumulated depreciation		(182,194	)		(4,717	)	Total property and equipment, net	$	189,612			—
	Total property and equipment, net	$	1,298,894		$	189,612

Accrued_Expenses_and_Other_Cur1

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended					12 Months Ended
	Sep. 30, 2014					Dec. 31, 2013
Payables and Accruals [Abstract]	'					'
Schedule of Accrued Liabilities [Table Text Block]	'					'
	Accrued expenses consist of the following:					Accrued expenses consist of the following:
		As of					As of December 31,
		September 30,		December 31,			2013		2012
		2014		2013		Accrued interest payable	$	207,945	$	—
	Accrued interest payable	$	—	$	207,945	Accrued compensation		19,894		—
	Accrued compensation		215,159		19,894	Other accrued expenses		15,784		10,406
	Other accrued expenses		241,104		15,784	Total	$	243,623	$	10,406
	Total	$	456,263	$	243,623

Private_Placement_Tables

Private Placement (Tables)	9 Months Ended													12 Months Ended
	Sep. 30, 2014													Dec. 31, 2013
Private Placement [Line Items]	'													'
Convertible Debt [Table Text Block]	'													'
														The debt discount is being amortized under the effective interest method over the term of the Convertible Notes.
														Face value of the Convertible Notes	$	5,500,009
														Discount-fair value of embedded conversion feature		(5,376,000	)
														Proceeds attributable to the Convertible Notes	$	124,009
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	'													'
	The Company calculated the fair value of the embedded conversion feature of the Convertible Notes at April 2, 2014 at the conversion features’ fair value, with the observable assumptions as provided in the table below.													Significant increases in either the probability or severity of default of the host instrument would result in a significantly lower fair value measurement.
		As of													As of
		2-Apr-14													16-May-13			31-Dec-13
	Stock price on valuation date	$	13.88											Stock price on valuation date	$	1.68		$	1.68
	Conversion price	$	3											Conversion price		2.07			2.07
	Fair value	$	26,790,177											Term (years)		1.25			0.26
														Expected volatility		60	%		60	%
														Dividend yield		0	%		0	%
														Weighted average risk-free interest rate		0.79	%		1.75	%
														Trials		20,000			20,000
														Aggregate fair value	$	5,376,000		$	5,573,000
Schedule of Derivative Instruments [Table Text Block]	'													'
														Derivative issuance expenses incurred in connection with the Private Placement are shown below and were expensed upon the issuance of the Convertible Notes, as substantially all the value was attributable to the derivative instruments.
															For the Year
															Ended
															December 31,
															2013
														Fair value of Financing Warrant	$	186,500
														Cash placement agent fee		538,393
														Legal and other expenses		162,169
														Total	$	887,062
Financing And Consulting Warrant [Member]	'													'
Private Placement [Line Items]	'													'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	'													'
	Provided below are the principal assumptions used in the measurement of the fair values of the Financing Warrant and the Consulting Warrant as of June 24, 2014 and December 31, 2013.													Provided below are the principal assumptions used in the measurement of the fair values of the Financings Warrant and the Consulting Warrant as of May 16, 2013 and December 31, 2013.
		As of June 24, 2014						As of December 31, 2013							As of May 16, 2012						As of December 31, 2013
		Financing			Consulting			Financing			Consulting				Financing			Consulting			Financing			Consulting
		Warrant			Warrant			Warrant			Warrant				Warrant			Warrant			Warrant			Warrant
	Stock price on valuation date	$	14.69		$	14.69		$	1.68		$	1.68		Stock price on valuation date	$	1.68		$	1.68		$	1.68		$	1.68
	Exercise price	$	3.6		$	0.04		$	2.49		$	0.04		Exercise price	$	2.49		$	0.04		$	2.49		$	0.04
	Term (years)		3.89			3.89			4.38			4.38		Term (years)		5			5			4.38			4.38
	Expected volatility		60	%		60	%		60	%		60	%	Expected volatility		60	%		60	%		60	%		60	%
	Dividend yield		0	%		0	%		0	%		0	%	Dividend yield		0	%		0	%		0	%		0	%
	Weighted average risk-free interest rate		1.33	%		1.33	%		1.75	%		1.75	%	Weighted average risk-free interest rate		0.79	%		0.79	%		1.75	%		1.75	%
	Number of warrants		152,778			278,228			220,905			278,228		Number of warrants		220,905			278,228			220,905			278,228
	Number of trials		20,000			20,000			20,000			20,000		Number of trials		20,000			20,000			20,000			20,000
	Aggregate fair value	$	1,733,000		$	4,019,000		$	175,000		$	529,000		Aggregate fair value	$	186,500		$	537,500		$	175,000		$	529,000

Stock_Based_Compensation_Table

Stock Based Compensation (Tables)	9 Months Ended													12 Months Ended
	Sep. 30, 2014													Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'													'
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'													'
	The Company estimated the fair value of stock options awarded during the nine months ended September 30, 2014 using the Black-Scholes option pricing model. The fair values of stock options granted were estimated using the following assumptions:													The fair value of the employee stock option granted was estimated using the following assumptions:
		Option Grants													12-Dec-13
		Awarded During the												Price of Company’s stock	$	1.68
		Nine Months Ended												Dividend yield		0.00%
		30-Sep-14												Expected volatility		60	%
	Stock Price	$	2.49 to $6.00											Risk-free interest rate		1.79	%
	Dividend Yield		0%											Expected life		5.93 years
	Expected Volatility		60%
	Risk-free interest rate		1.30% to 2.03%
	Expected Life		3.75 to 6.25 years
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'													'
	The following is a summary of the Company’s stock option activity during the nine months ended September 30, 2014:													A summary of the status of the Company’s stock option plans and the changes during the years ended December 31, 2013 and 2012, is presented in the table below:
		Number of			Weighted		Weighted			Weighted		Intrinsic			Number of			Weighted		Weighted		Weighted		Intrinsic
		Options			Average		Average			Average		Value			Options			Average		Average		Average		Value
					Exercise		Grant Date			Remaining								Exercise		Grant		Remaining
					Price		Fair Value			Life In Years								Price		Date Fair		Life In
	Outstanding, January 1, 2014		275,689		$	1.68	$	—			—	$	—							Value		Years
	Granted		1,542,477			4.63		2.6			—		—	Outstanding October 30, 2012 (inception)		—
	Exercised		—			—		—			—		—	Issued		—
	Forfeited		(166,981	)		2.52		1.44			—		—	Exercised		—
	Outstanding September 30, 2014		1,651,185		$	4.35	$	2.45			9.4	$	11,538,844	Forfeited		—
	Exercisable, January 1, 2014		17,231		$	1.68	$	—			—	$	—	Outstanding December 31, 2012		—
	Vested		340,580			4.88		—			—		—	Issued		275,689		$	1.68	$	0.23
	Exercised		—			—		—			—		—	Exercised		—
	Forfeited		—			—		—			—		—	Forfeited		—
	Exercisable, September 30, 2014		357,811		$	4.73	$	2.62			9.4	$	2,365,792	Outstanding December 31, 2013		275,689		$	1.68	$	0.23		9.9 years	$	—
														Exercisable at December 31, 2013		17,231		$	1.68	$	0.23		9.9 years	$	—
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	'													'
	The following table presents information related to stock options outstanding and exercisable at September 30, 2014:
		Options Outstanding					Options Exercisable
		Exercise			Outstanding		Weighted Average			Exercisable Number
		Price			Number of Options		Remaining Life In			of Options
							Years
		$	1.68			275,689		9.2			68,922
			2.49			370,864		9.3			14,411
			3.63			51,958		9.4			38,969
			4.99			99,214		9.5			14,260
			6			853,460		9.5			221,249
						1,651,185		9.4			357,811
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	'													'
	A summary of the activity related to RSUs for the nine months ended September 30, 2014 is presented below:
		Total			Weighted		Total Grant
					Average		Date Fair
					Grant		Value
					Date Fair
					Value
	Nonvested at January 1, 2014		—		$	—	$	—
	RSUs granted		484,194			12.4		6,002,925
	RSUs vested		(4,509	)		11.52		(51,948	)
	RSUs forfeited		(17,625	)		13.23		(233,178	)
	Nonvested at September 30, 2014		462,060		$	12.37		5,717,799
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	'													'
	The following tables summarize total stock based compensation costs recognized for the three and nine months ended September 30, 2014 and 2013:
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014			2013		2014			2013
	Stock options	$	325,634		$	—	$	1,070,939		$	—
	RSUs		381,856			—		389,482			—
	IR warrant		39,410			—		198,983			—
	Total	$	746,900		$	—	$	1,659,404		$	—
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]	'													'
	The total amount of stock-based compensation was reflected within the condensed statements of operations as:
		Three Months Ended September 30,					Nine Months Ended September 30,
		2014			2013		2014			2013
	Research and development	$	329,138		$	—	$	568,390		$	—
	General and administrative		165,228			—		657,738			—
	Marketing		252,534			—		433,276			—
	Total	$	746,900		$	—	$	1,659,404		$	—

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
	Significant components of the Company’s net deferred tax assets at December 31, 2013 and 2012 are as follows:
		December 31,
	Deferred tax assets:	2013			2012
	Net operating loss carryforwards	$	900,830		$	—
	Research and development costs		845,900			6,807
	Start-up and organizational costs		1,554			1,665
	Stock-based compensation		647			—
	Other accruals		90,680			—
	Total gross deferred tax assets		1,839,611			8,472
	Less: valuation allowance		-1,839,611			-8,472
	Deferred tax assets, net	$	—		$	—
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
	A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:
		For the Year			For the period
		Ended			October 30, 2012
		December 31,			(Inception)
		2013			through December
					31, 2012
	Tax benefit at federal statutory rate		-34	%		-34	%
	State income taxes		-5.8			-5.8
	Permanent difference:
	Stock based compensation		0.1			—
	Derivative instrument issuance - financing warrant		1.3			—
	General and administrative expense - consulting warrant		3.9			—
	Change in fair value of derivative liability		1.3			—
	Increase in valuation allowance		33.2			39.8
	Effective income tax rate		0	%		0	%

Business_Organization_Nature_o1

Business Organization, Nature of Operations (Details Textual)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Business Organization And Nature Of Operations [Line Items]	'	'
Stockholders Equity, Reverse Stock Split	'Effective March 26, 2014, pursuant to authority granted by the stockholders and the Board of Directors of the Company, the Company implemented a 1-for-3.99 reverse split of the Companys issued and outstanding common stock (the Reverse Split).	'1-for-3.99 reverse split

Liquidity_and_Management_Plans1

Liquidity and Management Plans (Details Textual) (USD $)

2 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

14 Months Ended

1 Months Ended

2 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

Dec. 31, 2012

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Oct. 29, 2012

Apr. 30, 2014

Mar. 31, 2014

Dec. 31, 2012

Sep. 30, 2014

Dec. 31, 2013

Oct. 29, 2012

Nov. 13, 2014

Mar. 31, 2014

Sep. 30, 2014

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Subsequent Event [Member]

Subsequent Event [Member]

IPO [Member]

Liquidity And Management Plans [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net income (numerator for basic and diluted earnings per share)

($21,287)

($5,847,998)

($1,173,363)

($36,579,100)

($3,242,809)

($5,521,081)

($5,542,368)

'

'

'

$0

$0

$0

'

'

'

'

Cash and Cash Equivalents, at Carrying Value, Total

994

18,420,480

3,854,489

18,420,480

3,854,489

1,953,780

1,953,780

0

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

'

'

'

'

'

'

4,600,000

'

'

'

'

'

Proceeds from Issuance of Common Stock

10,000

'

'

0

165,217

200,681

210,681

'

'

'

'

'

'

'

'

1,000,000

24,800,000

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

1,833,336

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period Shares Upon Conversion Of Debt Instrument Interest

'

'

'

96,792

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

'

'

210,527

'

'

5,353

'

'

Proceeds from Other Equity

'

'

'

900,000

0

'

'

'

700,000

300,000

'

700,000

'

'

'

'

'

Payments for Commissions

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders Equity Attributable to Parent, Total

-11,287

18,462,240

'

18,462,240

'

-5,345,092

-5,345,092

0

'

'

19

94

27

0

'

'

'

Working Capital Deficit

'

'

'

'

'

$5,629,982

$5,629,982

'

'

'

'

'

'

'

'

'

'

Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration

'

'

'

'

'

'

'

'

'

'

'

41,563

'

'

'

'

'

Reverse_Split_Details_Textual

Reverse Split (Details Textual)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Class of Stock [Line Items]	'	'
Stockholders Equity, Reverse Stock Split	'Effective March 26, 2014, pursuant to authority granted by the stockholders and the Board of Directors of the Company, the Company implemented a 1-for-3.99 reverse split of the Companys issued and outstanding common stock (the Reverse Split).	'1-for-3.99 reverse split

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Potentially dilutive securities	0	3,060,301	3,210,126	3,060,301	3,210,126	3,525,907
Convertible Notes Principal [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Potentially dilutive securities	0	0	2,650,858	0	2,650,858	2,650,858
Convertible Notes Accrued Interest [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Potentially dilutive securities	0	0	60,135	0	60,135	100,227
Consulting Warrant [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Potentially dilutive securities	0	278,228	278,228	278,228	278,228	278,228
Financing Warrant [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Potentially dilutive securities	0	152,778	220,905	152,778	220,905	220,905
IPO Warrants [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Potentially dilutive securities	'	460,000	0	460,000	0	'
IR Consulting Warrant [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Potentially dilutive securities	'	36,000	0	36,000	0	'
Stock Option [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Potentially dilutive securities	0	1,671,235	0	1,671,235	0	275,689
Restricted Stock Units (RSUs) [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Potentially dilutive securities	'	462,060	0	462,060	0	'

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details 1) (USD $)

Sep. 30, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Jun. 24, 2014

Dec. 31, 2013

16-May-12

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Jun. 24, 2014

Dec. 31, 2013

16-May-12

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Summary Of Significant Accounting Policies [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Liabilities

$0

$6,277,000

$0

$0

$0

$0

$0

$6,277,000

$0

$5,573,000

$0

$0

$5,573,000

$1,733,000

$175,000

$186,500

$0

$0

$175,000

$4,019,000

$529,000

$537,500

$0

$0

$529,000

Summary_of_Significant_Account5

Summary of Significant Accounting Policies (Details 2) (USD $)	2 Months Ended	12 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014
				Financing Warrant [Member]	Consulting Warrant [Member]	Convertible Notes Payable [Member]	Convertible Debt Securities [Member]
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'
Beginning balance	$0	$0	$0	'	'	'	'
Derivative Fair Value Of Derivative Net	0	6,100,000	'	-1,733,000	-4,019,000	-26,790,177	26,265,177
Change in fair value of conversion feature and warrants	0	177,000	'	'	'	'	'
Ending balance	$0	$6,277,000	$0	'	'	'	'

Summary_of_Significant_Account6

Summary of Significant Accounting Policies (Details Textual) (USD $)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	14 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'
Research and Development Expense, Total	$17,103	$3,699,057	$583,524	$6,184,762	$1,019,950	$2,109,890	$2,126,993
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	3,060,301	3,210,126	3,060,301	3,210,126	3,525,907	'
Stockholders Equity, Reverse Stock Split	'	'	'	'Effective March 26, 2014, pursuant to authority granted by the stockholders and the Board of Directors of the Company, the Company implemented a 1-for-3.99 reverse split of the Companys issued and outstanding common stock (the Reverse Split).	'	'1-for-3.99 reverse split	'
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down	0	'	'	'	'	4,725	4,725
Investment Warrants, Exercise Price	'	'	'	'	'	$2.49	'
Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs	17,000	'	'	'	'	2,108,000	2,108,000
Tax Basis of Investments, Cost for Income Tax Purposes	4,000	'	'	'	'	'	'
Deferred Tax Assets, Operating Loss Carryforwards, State and Local	'	'	'	'	'	$2,263,391	$2,263,391
Effective Income Tax Rate Reconciliation, Percent	0.00%	'	'	'	'	0.00%	'
Capitalized Organization Cost Amortization Period	'15 years	'	'	'	'	'	'
Convertible Notes Payable [Member]	'	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'
Debt Instrument, Convertible, Conversion Price	'	'	'	'	'	$2.07	$2.07
Percentage Exercise Price Of Warrants Determined Based On Conversion Price Of Convertible Notes	'	'	'	'	'	120.00%	'
Maximum [Member]	'	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'	'	'	'	'	'7 years	'
Minimum [Member]	'	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'	'	'	'	'	'3 years	'

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross, Total	$1,481,088	$194,329	$0
Less - Accumulated depreciation	-182,194	-4,717	0
Total property and equipment, net	1,298,894	189,612	0
Computer Software [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross, Total	369,453	114,876	0
Computer Hardware [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross, Total	492,852	36,240	0
Furniture and Fixtures [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross, Total	277,679	28,458	0
Leasehold Improvements [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross, Total	$341,104	$14,755	$0

Property_and_Equipment_Details1

Property and Equipment (Details Textual) (USD $)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	14 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2013
Property, Plant and Equipment [Line Items]	'	'	'	'	'	'	'
Depreciation, Depletion and Amortization, Total	$0	$142,093	$833	$196,898	$880	$4,717	$4,717
General and Administrative Expense [Member]	'	'	'	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'	'	'	'
Depreciation, Depletion and Amortization, Total	0	'	'	'	'	3,102	3,102
Research and Development Expense [Member]	'	'	'	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'	'	'	'
Depreciation, Depletion and Amortization, Total	$0	'	'	'	'	$1,615	$1,615

Accrued_Expenses_and_Other_Cur2

Accrued Expenses and Other Current Liabilities (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule of Accrued Liabilities [Line Items]	'	'	'
Accrued Liabilities, Current	$456,263	$243,623	$10,406
Accrued interest payable [Member]	'	'	'
Schedule of Accrued Liabilities [Line Items]	'	'	'
Accrued Liabilities, Current	0	207,945	0
Accrued compensation [Member]	'	'	'
Schedule of Accrued Liabilities [Line Items]	'	'	'
Accrued Liabilities, Current	215,159	19,894	0
Other accrued expenses [Member]	'	'	'
Schedule of Accrued Liabilities [Line Items]	'	'	'
Accrued Liabilities, Current	$241,104	$15,784	$10,406

Private_Placement_Details

Private Placement (Details) (USD $)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	14 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2013
Debt Instrument [Line Items]	'	'	'	'	'	'	'
Discount-fair value of embedded conversion feature	$0	$0	($90,000)	($21,217,177)	$0	($197,000)	($197,000)
Proceeds attributable to the Convertible Notes	0	'	'	0	5,500,009	5,500,009	5,500,009
Senior Secured Convertible Notes [Member]	'	'	'	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'	'	'	'
Face value of the Convertible Notes	'	'	'	'	'	5,500,009	5,500,009
Discount-fair value of embedded conversion feature	'	'	'	'	'	-5,376,000	'
Proceeds attributable to the Convertible Notes	'	'	'	'	'	$124,009	'

Private_Placement_Details_1

Private Placement (Details 1) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012	16-May-13	Dec. 31, 2013	Sep. 30, 2014	Apr. 02, 2014
				Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Convertible Notes Payable [Member]
Private Placement [Line Items]	'	'	'	'	'	'	'
Stock price on valuation date	'	$1.68	'	$1.68	$1.68	'	$13.88
Conversion price	'	'	'	$2.07	$2.07	$3	$3
Term (years)	'	'	'	'1 year 3 months	'3 months 4 days	'	'
Expected volatility	'	'	'	60.00%	60.00%	'	'
Dividend yield	'	'	'	0.00%	0.00%	'	'
Weighted average risk-free interest rate	'	'	'	0.79%	1.75%	'	'
Trials	'	'	'	20,000	20,000	'	'
Fair value	$0	$6,277,000	$0	$5,376,000	$5,573,000	'	$26,790,177

Private_Placement_Details_2

Private Placement (Details 2) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012	16-May-12	Jun. 24, 2014	Dec. 31, 2013	16-May-12	Jun. 24, 2014	Dec. 31, 2013	Sep. 30, 2014
				Consulting Warrant [Member]	Consulting Warrant [Member]	Consulting Warrant [Member]	Financing Warrant [Member]	Financing Warrant [Member]	Financing Warrant [Member]	Financing Warrant [Member]
Private Placement [Line Items]	'	'	'	'	'	'	'	'	'	'
Stock price on valuation date	'	$1.68	'	$1.68	$14.69	$1.68	$1.68	$14.69	$1.68	'
Exercise price	'	'	'	$0.04	$0.04	$0.04	$2.49	$3.60	$2.49	$3.60
Term (years)	'	'	'	'5 years	'3 years 10 months 20 days	'4 years 4 months 17 days	'5 years	'3 years 10 months 20 days	'4 years 4 months 17 days	'
Expected volatility	'	'	'	60.00%	60.00%	60.00%	60.00%	60.00%	60.00%	'
Dividend yield	'	'	'	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	'
Weighted average risk-free interest rate	'	'	'	0.79%	1.33%	1.75%	0.79%	1.33%	1.75%	'
Number of warrants	'	'	'	278,228	278,228	278,228	220,905	152,778	220,905	'
Number of trials	'	'	'	20,000	20,000	20,000	20,000	20,000	20,000	'
Aggregate fair value	$0	$6,277,000	$0	$537,500	$4,019,000	$529,000	$186,500	$1,733,000	$175,000	'

Private_Placement_Details_3

Private Placement (Details 3) (USD $)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	14 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2013
Derivative [Line Items]	'	'	'	'	'	'	'
Fair value of Financing Warrant	$0	'	'	$0	$724,000	$724,000	$724,000
Total	0	0	9,040	0	887,062	887,062	887,062
Convertible Notes Payable [Member]	'	'	'	'	'	'	'
Derivative [Line Items]	'	'	'	'	'	'	'
Fair value of Financing Warrant	'	'	'	'	'	186,500	'
Cash placement agent fee	'	'	'	'	'	538,393	'
Legal and other expenses	'	'	'	'	'	162,169	'
Total	'	'	'	'	'	$887,062	'

Private_Placement_Details_Text

Private Placement (Details Textual) (USD $)

2 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

14 Months Ended

9 Months Ended

2 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

2 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2012

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2012

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Jun. 24, 2014

16-May-12

Dec. 31, 2012

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Jun. 24, 2014

16-May-12

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Aug. 16, 2014

Apr. 02, 2014

Dec. 31, 2013

16-May-13

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Common Stock [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Financing Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Consulting Warrant [Member]

Financing And Consulting Warrant [Member]

Financing And Consulting Warrant [Member]

Financing And Consulting Warrant [Member]

Financing And Consulting Warrant [Member]

Financing And Consulting Warrant [Member]

InterestPayable [Member]

IR Consulting Warrant [Member]

IR Consulting Warrant [Member]

IR Consulting Warrant [Member]

IR Consulting Warrant [Member]

IR Incentive Warrant [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Senior Secured Convertible Notes [Member]

Senior Secured Convertible Notes [Member]

Senior Secured Convertible Notes [Member]

Senior Secured Convertible Notes [Member]

Senior Secured Convertible Notes [Member]

Senior Secured Convertible Notes [Member]

Maximum [Member]

Minimum [Member]

Principal [Member]

Accrued interest payable [Member]

Maximum [Member]

Minimum [Member]

Private Placement [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Securities Purchase Agreement Initiation Date

'

'

'

16-May-13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$5,500,009

'

'

$5,500,009

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

'

6.00%

'

'

'

'

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

16-Aug-14

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3

'

$3

$2.07

$2.07

$4.14

$2.07

$2.07

'

'

'

$4.14

$2.07

Debt Instrument Interest Rate, Event Of Default

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12.00%

'

'

'

'

'

'

'

'

'

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

0

3,060,301

3,210,126

3,060,301

3,210,126

3,525,907

'

'

0

152,778

220,905

152,778

220,905

220,905

'

'

0

278,228

278,228

278,228

278,228

278,228

'

'

'

'

'

'

'

'

36,000

0

36,000

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Unamortized Discount (Premium), Net, Total

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,376,000

'

'

'

'

'

Amortization of Debt Discount (Premium)

0

0

206,370

964,851

262,506

705,289

705,289

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Remaining Discount Amortization Period

'

'

'

'

'

'7 months 6 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increase (Decrease) in Derivative Liabilities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

1,000

5,048,000

5,500

20,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Payments for Fees

'

'

'

'

'

'

'

'

'

'

'

'

538,393

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale Of Warrants In Cash

'

'

'

'

'

'

'

'

'

'

'

'

1,000

'

'

'

'

'

'

'

1,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Aggregate Exercise Price

'

'

'

'

'

'

'

'

'

'

'

550,000

'

550,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage Exercise Price Of Warrants Determined Based On Conversion Price Of Convertible Notes

'

'

'

'

'

'

'

'

'

'

'

120.00%

'

120.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Investment Warrants, Exercise Price

'

'

'

'

'

$2.49

'

'

'

'

'

$3.60

'

$2.49

'

'

'

'

'

'

$0.04

'

'

'

'

'

'

'

'

'

'

'

$7.80

'

$7.80

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage Of Warrants Exercise Based On Convertible Notes Conversion Price

'

'

'

'

'

'

'

'

'

'

'

120.00%

'

120.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Issued To Purchase Common Stock, Shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

278,228

'

'

'

'

'

'

'

'

'

'

'

36,000

'

5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value Adjustment of Warrants

0

'

'

0

724,000

724,000

724,000

'

'

'

'

186,500

'

186,500

'

'

'

'

'

537,500

'

537,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

290,219

'

'

'

'

'

5,500,009

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

1,833,336

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

96,792

'

'

'

'

'

1,833,336

'

'

'

'

'

'

'

'

2,650,858

100,227

'

'

Debt Conversion, Converted Instrument, Expiration or Due Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2-Oct-14

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Beneficial Conversion Feature

0

0

90,000

21,217,177

0

197,000

197,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,376,000

'

'

'

'

'

Gains (Losses) on Extinguishment of Debt

'

0

0

2,084,368

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Conversion of Convertible Securities

'

'

'

'

'

'

'

1,930,128

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Conversion of Convertible Securities

'

'

'

26,790,177

'

'

'

19

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Adjustments to Additional Paid in Capital, Other

'

'

'

5,752,000

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value Assumptions, Exercise Price

'

'

'

'

'

'

'

'

'

$3.60

'

$3.60

'

$2.49

$3.60

$2.49

'

'

'

'

'

$0.04

$0.04

$0.04

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Notes Payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,376,000

'

'

'

'

'

Interest Payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

207,945

0

'

'

'

'

Debt Conversion, Original Debt, Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$10,000,000

'

'

'

'

'

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

'

'

'

'

'

Commitments_and_Contingencies_

Commitments and Contingencies (Details Textual) (USD $)

2 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

14 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

0 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

Dec. 31, 2012

Dec. 31, 2012

Sep. 30, 2014

Sep. 30, 2013

Jun. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2014

Nov. 13, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

acre

acre

Common Stock [Member]

Cheryl Sanchez [Member]

Stephen Rizzone [Member]

Michael Leabman [Member]

Balzer Family Investments, L.P [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

IR Consulting Warrant [Member]

IR Consulting Warrant [Member]

IR Incentive Warrant [Member]

Stephen Rizzone [Member]

Commitments and Contingencies [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Investor Relations Agreement, Initiation Date

'

'

'

'

13-Jan-14

13-Jan-14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Exercise Price, Representing IPO Price Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

130.00%

'

Warrants Vesting, Each Month Of Service

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000

'

Warrants Vesting Thereafter, Each Month Of Service

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000

'

Warrant Vested During Period, Shares

'

'

'

'

'

25,800

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock based compensation expense

'

$0

$746,900

$0

'

$1,659,404

$0

$16,148

$16,148

'

'

'

'

'

'

'

'

$39,410

$198,983

'

Area of Land

'

'

'

'

'

'

'

3,562

3,562

'

'

'

'

'

'

'

'

'

'

'

Operating Leases, Rent Expense

'

'

'

'

'

8,548

'

6,055

'

'

'

'

'

36,720

'

'

'

'

'

'

Cash Compensation For Services Received Per Month 1

'

'

'

'

'

8,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Lease Expiration Date

'

'

'

'

'

'

'

4-Jun-14

'

'

'

'

'

'

'

'

'

'

'

'

Extended Lease Expiration Date

'

'

'

'

'

30-Sep-14

'

4-Sep-14

'

'

'

'

'

'

'

'

'

'

'

'

Terms Of Incentive Warrant Market Maker

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

250,000

Investment Advisory Fees

'

'

'

'

'

'

'

'

'

'

21,550

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Issued for Services

'

'

'

'

'

900,000

'

'

'

2

35,464

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

210,527

88,882

'

'

'

5,353

'

'

'

'

'

Stock Repurchased During Period, Value

'

'

'

'

'

'

'

'

'

'

29,533

'

'

'

'

'

'

'

'

'

Stock Repurchased During Period, Shares

'

'

'

'

'

'

'

'

'

'

74,068

'

'

'

'

'

'

'

'

'

Deferred Compensation Arrangement with Individual, Compensation Expense

'

'

'

'

'

'

'

'

'

'

'

150,000

250,000

'

'

'

300,000

'

'

'

Accrued Bonuses, Current

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30,000

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

'

'

'

'

'

'

'

'

'

'

'

'10 years

'10 years

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

0

'

'

'

'

1,542,477

'

275,689

'

'

'

275,689

57,644

'

'

80,201

'

'

'

'

Defined Benefit Plan, Description of Nature of Event Resulting in Special or Contractual Termination Benefits Recognized During Period

'

'

'

'

'

'

'

'

'

'

'

'

'(i) one year of his base salary at the rate then in effect, (ii) a performance bonuses each equal to the total performance bonuses paid to Mr. Leabman in the calendar year immediately preceding Mr. Leabmans termination or resignation (iii) reimbursement of Mr. Leabmans cost of COBRA coverage for one year, and (iv) twenty-five percent (25%) of the options to purchase shares of common stock subject to Mr. Leabmans option awards described above will vest immediately and become exercisable, and, along with any previously vested and unexercised options, may be exercised by Mr. Leabman within one year following his termination or resignation

'

'

'

'

'

'

'

Sale of Stock, Percentage of Ownership before Transaction

'

'

'

'

'

'

'

'

'

'

'

50.00%

3.00%

'

'

'

'

'

'

'

Performance Based Bonus Percentage

'

'

'

'

'

'

'

20.00%

'

'

'

'

'

'

'

'

'

'

'

'

Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration

'

'

'

'

'

'

'

'

'

41,563

'

'

'

'

'

'

'

'

'

'

Development Stage Entities, Stock Issued, Value, Issued for Noncash Consideration

'

'

'

'

'

500,000

0

'

'

0

'

'

'

'

'

'

'

'

'

'

Payments for Tenant Improvements

'

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating Leases Expiration Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'60 months

'

'

'

'

'

'

Payments for Rent

'

'

'

'

'

400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating Leases, Rent Expense, Net

'

'

'

'

'

'

'

'

'

'

'

'

'

$6,732

'

'

'

'

'

'

Stockholders_Equity_Deficit_De

Stockholders' Equity (Deficit) (Details Textual) (USD $)

2 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

14 Months Ended

2 Months Ended

1 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

9 Months Ended

9 Months Ended

9 Months Ended

Dec. 31, 2012

Sep. 30, 2014

Sep. 30, 2013

Jun. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Mar. 26, 2014

Dec. 31, 2012

Nov. 08, 2012

31-May-13

7-May-13

Jan. 31, 2013

Jan. 28, 2013

Mar. 31, 2013

Mar. 04, 2013

Apr. 30, 2014

Mar. 31, 2014

Sep. 30, 2014

Mar. 07, 2014

Sep. 30, 2014

Apr. 02, 2014

Sep. 30, 2014

Sep. 30, 2014

DvineWave Holdings LLC [Member]

DvineWave Holdings LLC [Member]

MS Investments [Member]

MS Investments [Member]

Michael Leabman [Member]

Michael Leabman [Member]

Absolute Ventures LLC [Member]

Absolute Ventures LLC [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

IPO [Member]

IPO [Member]

Over-Allotment Option [Member]

Initial Public Offering Warrant [Member]

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares Authorized

18,000,000

50,000,000

'

'

50,000,000

'

40,000,000

40,000,000

60,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Authorized

5,000,000

10,000,000

'

'

10,000,000

'

0

0

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

'

'

'

'

1,924,813

'

20,050

'

80,201

'

668,337

'

'

'

4,600,000

'

'

'

600,000

'

Shares Issued, Price Per Share

'

'

'

'

'

'

'

'

'

'

$0.01

'

$0.24

'

$0.01

'

$0.24

'

'

'

'

'

$6

'

'

Proceeds from Issuance or Sale of Equity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,000,000

'

$25,214,596

'

'

'

Payments for Underwriting Expense

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

177,404

'

'

'

Proceeds from Issuance Initial Public Offering

'

'

'

'

24,872,170

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

24,783,851

'

'

'

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

0

3,060,301

3,210,126

'

3,060,301

3,210,126

3,525,907

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

460,000

Investment Warrants, Exercise Price

'

'

'

'

'

'

$2.49

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$7.50

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

210,527

'

'

'

'

'

Sale of Stock, Price Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

'

'

'

Proceeds from Other Equity

'

'

'

'

900,000

0

'

'

'

'

'

'

'

'

'

'

'

700,000

300,000

700,000

'

'

'

'

'

Payments for Commissions

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Equity Lock up Period

'

'

'

'

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Equity Voting Control Period

'

'

'

'1 year

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Common Stock

10,000

'

'

'

0

165,217

200,681

210,681

'

10,000

'

4,800

'

417

'

160,000

'

'

'

'

'

24,800,000

'

'

'

Common Stock, Discount on Shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,208,000

'

'

Payments of Stock Issuance Costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$430,745

'

'

'

Warrants Expiration Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2-Apr-24

Stock_Based_Compensation_Detai

Stock Based Compensation (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Stock Price	'	$1.68
Dividend Yield	0.00%	0.00%
Expected Volatility	60.00%	60.00%
Risk-free interest rate, Minimum	1.30%	'
Risk-free interest rate	'	1.79%
Risk-free interest rate, Maximum	2.03%	'
Expected Life	'	'5 years 11 months 5 days
Maximum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Stock Price	$6	'
Expected Life	'6 years 3 months	'
Minimum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Stock Price	$2.49	'
Expected Life	'3 years 9 months	'

Stock_Based_Compensation_Detai1

Stock Based Compensation (Details 1) (USD $)	2 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of Options, Outstanding	0	275,689	0
Number of Options, Granted	0	1,542,477	275,689
Number of Options, Exercised	0	0	0
Number of Options, Forfeited	0	-166,981	0
Number of Options, Outstanding	0	1,651,185	275,689
Number of Options, Exercisable	'	17,231	'
Number of Options, Vested	'	340,580	'
Number of Options, Exercisable	'	357,811	17,231
Weighted Average Exercise Price, Outstanding	'	$1.68	'
Weighted Average Exercise Price, Granted	'	$4.63	$1.68
Weighted Average Exercise Price, Exercised	'	$0	'
Weighted Average Exercise Price, Forfeited	'	$2.52	'
Weighted Average Exercise Price, Outstanding	'	$4.35	$1.68
Weighted Average Exercise Price, Exercisable	'	$1.68	$1.68
Weighted Average Exercise Price, Vested	'	$4.88	'
Weighted Average Exercise Price, Exercisable	$1.68	$4.73	$1.68
Weighted Average Grant Date Fair Value, Outstanding	'	$0	'
Weighted Average Grant Date Fair Value, Granted	'	$2.60	$0.23
Weighted Average Grant Date Fair Value, Exercised	'	$0	'
Weighted Average Grant Date Fair Value, Forfeited	'	$1.44	'
Weighted Average Grant Date Fair Value, Outstanding	'	$2.45	$0
Weighted Average Grant Date Fair Value, Exercisable	'	'	$0.23
Weighted Average Grant Date Fair Value, Exercisable	$0.23	$2.62	'
Weighted Average Remaining Life in Years, Outstanding	'	'9 years 4 months 24 days	'9 years 10 months 24 days
Weighted Average Remaining Life in Years, Exercisable	'	'9 years 4 months 24 days	'9 years 10 months 24 days
Intrinsic Value, Outstanding	'	$0	'
Intrinsic Value, Exercised	'	0	'
Intrinsic Value, Outstanding	'	11,538,844	0
Intrinsic Value, Exercisable	'	0	0
Intrinsic Value, Exercisable	$0	$2,365,792	$0

Stock_Based_Compensation_Detai2

Stock Based Compensation (Details 2) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012	Oct. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Exercise Price	$4.35	$1.68	'	'
Number of Options, Outstanding	1,651,185	275,689	0	0
Weighted Average Remaining Life in Year Exercisable	'9 years 4 months 24 days	'9 years 10 months 24 days	'	'
Number of Option Exercisable	357,811	17,231	'	'
Stock Option One [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Exercise Price	$1.68	'	'	'
Number of Options, Outstanding	275,689	'	'	'
Weighted Average Remaining Life in Year Exercisable	'9 years 2 months 12 days	'	'	'
Number of Option Exercisable	68,922	'	'	'
Stock Option Two [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Exercise Price	$2.49	'	'	'
Number of Options, Outstanding	370,864	'	'	'
Weighted Average Remaining Life in Year Exercisable	'9 years 3 months 18 days	'	'	'
Number of Option Exercisable	14,411	'	'	'
Stock Option Three [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Exercise Price	$3.63	'	'	'
Number of Options, Outstanding	51,958	'	'	'
Weighted Average Remaining Life in Year Exercisable	'9 years 4 months 24 days	'	'	'
Number of Option Exercisable	38,969	'	'	'
Stock Option Four [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Exercise Price	$4.99	'	'	'
Number of Options, Outstanding	99,214	'	'	'
Weighted Average Remaining Life in Year Exercisable	'9 years 6 months	'	'	'
Number of Option Exercisable	14,260	'	'	'
Stock Option Five [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Exercise Price	$6	'	'	'
Number of Options, Outstanding	853,460	'	'	'
Weighted Average Remaining Life in Year Exercisable	'9 years 6 months	'	'	'
Number of Option Exercisable	221,249	'	'	'

Stock_Based_Compensation_Detai3

Stock Based Compensation (Details 3) (USD $)	9 Months Ended
	Sep. 30, 2014
Restricted Stock [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
RSUs vested	504
Restricted Stock Units (RSUs) [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Nonvested at January 1, 2014	0
RSUs granted	484,194
RSUs vested	-4,509
RSUs forfeited	-17,625
Nonvested at September 30, 2014	462,060
Weighted Average Grant Date Fair Value, Nonvested at January 1, 2014	0
Weighted Average Grant Date Fair Value, RSU Granted	12.4
Weighted Average Grant Date Fair Value, RSUs vested	11.52
Weighted Average Grant Date Fair Value, RSUs forfeited	13.23
Weighted Average Grant Date Fair Value, Nonvested at September 30, 2014	12.37
Total Grant Date Fair Value, Nonvested at January 1, 2014	0
Total Grant Date Fair Value, RSU Granted	6,002,925
Total Grant Date Fair Value, RSUs vested	-51,948
Total Grant Date Fair Value, RSUs forfeited	-233,178
Total Grant Date Fair Value, Nonvested at September 30, 2014	5,717,799

Stock_Based_Compensation_Detai4

Stock Based Compensation (Details 4) (USD $)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	14 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'	'	'	'
Share-based Compensation, Total	$0	$746,900	$0	$1,659,404	$0	$16,148	$16,148
Restricted Stock [Member]	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'	'	'	'
Allocated Share-based Compensation Expense	'	381,856	0	389,482	0	'	'
IR Consulting Warrant Member [Member]	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'	'	'	'
Allocated Share-based Compensation Expense	'	39,410	0	198,983	0	'	'
Employee Stock Option [Member]	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'	'	'	'
Allocated Share-based Compensation Expense	'	$325,634	$0	$1,070,939	$0	'	'

Stock_Based_Compensation_Detai5

Stock Based Compensation (Details 5) (USD $)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	14 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'	'	'	'
Share-based Compensation, Total	$0	$746,900	$0	$1,659,404	$0	$16,148	$16,148
Research and Development Expense [Member]	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'	'	'	'
Allocated Share-based Compensation Expense	'	329,138	0	568,390	0	'	'
General and Administrative Expense [Member]	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'	'	'	'
Allocated Share-based Compensation Expense	'	165,228	0	657,738	0	'	'
Selling and Marketing Expense [Member]	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'	'	'	'
Allocated Share-based Compensation Expense	'	$252,534	$0	$433,276	$0	'	'

Stock_Based_Compensation_Detai6

Stock Based Compensation (Details Textual) (USD $)

1 Months Ended

2 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

3 Months Ended

1 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

9 Months Ended

1 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Sep. 30, 2014

Dec. 31, 2013

9-May-13

Mar. 31, 2014

Sep. 30, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2014

Aug. 31, 2014

Sep. 30, 2014

Mar. 15, 2014

Dec. 31, 2013

Aug. 31, 2014

Jul. 31, 2014

Sep. 30, 2014

Sep. 30, 2014

Mar. 26, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Mar. 26, 2014

Sep. 30, 2014

Mar. 26, 2014

Mar. 10, 2014

Jun. 30, 2014

Mar. 31, 2014

Sep. 30, 2014

Mar. 06, 2014

Dec. 31, 2014

Mar. 31, 2014

Sep. 30, 2014

Sep. 30, 2014

Mar. 15, 2014

Feb. 27, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Jan. 07, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Aug. 31, 2014

Subsequent Event [Member]

Restricted Stock Units (RSUs) [Member]

Two New Independent Directors [Member]

Two New Independent Directors [Member]

Two New Independent Directors [Member]

Two New Independent Directors [Member]

Mr. Cesar Johnston Restricted Stock Units RSUs [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

First Amendment To 2013 Equity Incentive Plan [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Stock Plan 2013 [Member]

Stock Plan 2013 [Member]

Stock Plan 2013 [Member]

Stock Plan 2013 [Member]

Stock Plan 2013 [Member]

Stock Plan 2013 [Member]

Stock Plan 2013 [Member]

Stock Plan 2013 [Member]

Employee Stock Option [Member]

Restricted Stock [Member]

Performance Shares [Member]

Subsequent Event [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Employees And Consultants [Member]

Mr.Michael Leabman [Member]

Mr.Michael Leabman [Member]

Mr. George Holmes [Member]

Mr. George Holmes [Member]

Mr. Rizzone [Member]

Mr. Rizzone [Member]

Mr. Rizzone [Member]

Mr. Rizzone [Member]

Consultant [Member]

Consultant [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Restricted Stock Units (RSUs) [Member]

Two New Independent Directors [Member]

Two New Independent Directors [Member]

Two New Independent Directors [Member]

Employees And Consultants [Member]

Mr.Michael Leabman [Member]

Interim Chief Financial Officer [Member]

Mr. George Holmes [Member]

Mr. George Holmes [Member]

Other Employees And Consultants [Member]

Other Employees And Consultants [Member]

Two New Independent Directors [Member]

Mr. Cesar Johnston Restricted Stock Units RSUs [Member]

Restricted Stock Units (RSUs) [Member]

Subsequent Event [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

'

'

'

'

'

'

'

'

1,056,980

'

'

'

'

'

'

'

'

'

1,042,167

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage Issuance Of Stock Under Plan Based Number Of Common Stock Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options

$240,225

'

'

'

'

'

'

$240,225

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$2,937,130

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

'

0

'

'

'

'

1,542,477

275,689

'

80,201

'

'

'

'

'

'

80,201

'

'

'

228,500

'

251,474

'

'

44,836

'

496,546

275,689

'

89,672

'

'

'

'

'

'

'

249,875

'

34,781

'

'

457,644

57,644

80,201

319,799

'

'

'

25,979

'

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

'

'

'

'

'

'

$4.63

$1.68

'

$4.99

'

'

'

'

'

'

$4.99

'

'

'

'

'

$6

'

'

'

'

$6

$1.68

'

$6

'

'

'

'

'

'

'

'

'

$5.45

'

'

$2.49

'

'

'

'

'

'

$3.63

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

'3 years 8 months 12 days

'

'

'

'

'

'

'

'

'

'3 years 6 months 4 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2 years 11 months 16 days

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'vests 25% of the award on the anniversary of the employee’s date of hire and then will vest 1/48th of the initial award monthly during the following 36 months

'

'

'

'

'

'vests 6/48 of the award on the grant date and 1/48 of the award on the last day of each of the subsequent 42 months

'

'

'

'1/48

'vests 6/48th of the award on the grant date and 1/48th of the award on the last day of each of the subsequent 42 months.

'

'

'vests 25% of the award on September 30, 2014 and 1/48th of the award on the last day of each of the subsequent 36 months.

'

'

'

'

'

'

'

'

'

'vests 25% of the award on September 30, 2014 and 1/48th of the award on the last day of each of the subsequent 36 months.

'

'

'

'vested 3/48ths on the date of grant, and will vest 1/48th monthly over the following 45 months.

'vest 25% of the award on October 1, 2014 and then will vest 1/48th of the initial award monthly for the following 36 months

'vest 25% of the award on October 1, 2014 and then will vest 1/48th of the initial award monthly for the following 36 months

'

'vest 25% of the award on the later of the first anniversary of the date they started working for the Company or October 1, 2014 and then will vest 1/48th of the initial award monthly for the following 36 months

'

'vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award

'Pursuant to the 2013 Stock Plan, each option grant must have had an exercise price at or above the fair market value of the Company’s common stock on the date of grant in the case of a non-statutory stock option, or until the Company’s securities are listed on a recognized exchange, at 85% of fair value (as determined) under the 2013 Stock Plan of DvineWave Inc.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'seven succeeding three month anniversaries of the grant date

'

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

258,373

'

'

'

'

'

'

258,373

'

'

'

'

'

'

'

'

'

229,365

'

'

'

'

'

844,643

'

'

'

'

'

1,667,784

'

303,869

'

'

'

'

'

'

'

'

'

100,000

100,000

'

'

'

'

'

'

762,699

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

'

'

'

'

'

'

'

'

'

'

484,194

'

'

'

'

100,000

'

'

'

86,823

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,035

'

'

'

'

'

'

'

'

'

'

'

'

'

20,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

49,590

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

'

'

'

'

'

'

'

'

'

'

-4,509

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,009

'

'

'

'

'

'

'

'

'

'

'

'

504

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options

'

'

'

'

'

'

'

'

'

'

$5,328,318

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

'

'

25.00%

25.00%

25.00%

25.00%

'

'

'

25.00%

'

25.00%

25.00%

25.00%

25.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25.00%

'

'

25.00%

25.00%

'

'

25.00%

'

'

'

'

'

'

'

'

25.00%

25.00%

25.00%

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,335,967

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value

'

'

'

'

'

'

'

'

'

'

6,002,925

'

'

'

'

1,356,000

'

'

'

981,100

3,023,055

'

'

'

'

593,180

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

28-Mar-18

'

'

'

'

28-Mar-18

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'

'

'

'

'

'

'

'36 months

'

'

'

'

'

'4 years

'

'

'

'4 years

'4 years

'

'

'

'4 years

'0 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'10 years

'

'

'

'

'10 years

'10 years

'

'

'

'

'0 years

'

'

'10 years

'

'

'

'

'

'

'

'

'

'10 years

'

'

'0 years

'

'

'

'

'

'

'10 years

'

'

'

Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

428,987

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

211,184

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Income_Taxes_Details

Income Taxes (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:	'	'
Net operating loss carryforwards	$900,830	$0
Research and development costs	845,900	6,807
Start-up and organizational costs	1,554	1,665
Stock-based compensation	647	0
Other accruals	90,680	0
Total gross deferred tax assets	1,839,611	8,472
Less: valuation allowance	-1,839,611	-8,472
Deferred tax assets, net	$0	$0

Income_Taxes_Details_1

Income Taxes (Details 1)	2 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2013
Income Tax Examination [Line Items]	'	'
Tax benefit at federal statutory rate	-34.00%	-34.00%
State income taxes	-5.80%	-5.80%
Permanent difference:	'	'
Stock based compensation	0.00%	0.10%
Change in fair value of derivative liability	0.00%	1.30%
Increase in valuation allowance	39.80%	33.20%
Effective income tax rate	0.00%	0.00%
Financing Warrant [Member]	'	'
Permanent difference:	'	'
Derivative instrument issuance - financing warrant	0.00%	1.30%
Consulting Warrant [Member]	'	'
Permanent difference:	'	'
General and administrative expense - consulting warrant	0.00%	3.90%

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	14 Months Ended
	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2013
Income Tax Disclosure [Line Items]	'	'	'	'	'	'	'
Net loss	($21,287)	($5,847,998)	($1,173,363)	($36,579,100)	($3,242,809)	($5,521,081)	($5,542,368)
Deferred Tax Assets, Valuation Allowance	8,472	'	'	'	'	1,839,611	1,839,611
Deferred Tax Assets, Operating Loss Carryforwards, State and Local	'	'	'	'	'	2,263,391	2,263,391
Operating Loss Carry forwards Expiration Period	'	'	'	'	'	'2033	'
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	'	'	'	'	'	$1,831,139	'

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (USD $)

2 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

14 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

1 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Mar. 26, 2014

Jun. 30, 2014

Mar. 31, 2014

Nov. 13, 2014

Mar. 31, 2014

Mar. 07, 2014

Feb. 25, 2014

Mar. 31, 2014

Jan. 13, 2014

Mar. 31, 2014

Mar. 31, 2014

Jul. 31, 2014

Nov. 13, 2014

Nov. 13, 2014

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Nov. 13, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Jul. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

IR Consulting Warrant [Member]

IR Consulting Warrant [Member]

IR Incentive Warrants [Member]

Equity Incentive Plan 2013 [Member]

Employee Stock Option [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Employees And Consultants [Member]

Employees And Consultants [Member]

Other Employees [Member]

Chief Technical Officer [Member]

Chief Financial Officer [Member]

Vice President [Member]

Vice President [Member]

Director [Member]

Director [Member]

Equity Incentive Plan 2013 [Member]

Equity Incentive Plan 2013 [Member]

Restricted Stock Units (RSUs) [Member]

Equity Incentive Plan 2013 [Member]

Non-Employee Equity Compensation Plan 2014 [Member]

Subsequent Event [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Payments of Stock Issuance Costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

0

'

'

'

'

'

1,542,477

'

275,689

'

'

'

'

'

80,201

'

'

'

'

'

'

'

261,686

3,836

'

249,875

457,644

5,100

319,799

57,644

80,201

80,201

'

25,979

34,781

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'36 months

'

'

'

'

'6 months

'

'4 years

'

'

'

'

'36 months

'

'

'45 months

'36 months

'36 months

'4 years

'1 year

'1 year

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

28-Mar-18

'

'

'

'

1-Oct-14

'

'

'

1-Oct-14

1-Oct-14

28-Mar-18

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

'

'

'

'

'

'

$4.63

'

$1.68

'

'

'

'

'

$4.99

'

'

'

'

'

'

'

'

'

'

'

$2.49

'

'

'

'

'

'

$3.63

$5.47

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'3,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

'

'

25.00%

25.00%

25.00%

25.00%

'

'

'

'

'

25.00%

25.00%

'

25.00%

'

'

'

'

'

'

'

'

'

25.00%

'

25.00%

'

'

'

25.00%

25.00%

'

25.00%

25.00%

Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

36,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

130.00%

'

30.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'4 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'10 years

Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'18%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Stock, Number of Shares Issued in Transaction

'

'

'

'

'

'

'

'

'

'

'

'

'

'

210,526

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Stock, Price Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Common Stock

'

$10,000

'

'

'

'

$0

$165,217

$200,681

$210,681

'

'

'

'

$1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Authorized

5,000,000

5,000,000

'

10,000,000

'

'

10,000,000

'

0

0

10,000,000

'

'

'

'

'

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale Of Stock Lock Up Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Excess Stock, Shares Authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

60,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

'

'

'

'

5,353

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'